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RESUMEN 
Las modificaciones post-traduccionales reguladas por la ubiquitina y la familia de 
la ubiquitina están implicadas en diversas funciones vitales en las células 
eucariotas. Entre todas las proteínas de la familia de la ubiquitina, NEDD8 es la 
que comparte mayor similitud con la ubiquitina tanto en su secuencia como en 
su estructura. A pesar de esta similitud, NEDD8 tiene su propio conjunto de 
enzimas que resulta en una distinta cascada de conjugación. Las culinas, forman 
parte de la familia de ligasas de ubiquitina CRLs (Culina-RING) y representan 
los sustratos mejor caracterizadas de NEDD8, por ello, la mayoría de los estudios 
sobre NEDDilación se han enfocado principalmente en la regulación y la 
degradación de proteínas ubiquitiladas. Recientemente, otros sustratos 
relevantes de NEDD8 han sido identificados lo cual sugiere que la NEDDilación 
está vinculada en muchos más procesos biológicos esenciales para la célula. De 
hecho, NEDD8 responde a situaciones de estrés celular en comunicación 
cruzada con la ubiquitina, sin embargo, todavía se desconoce el papel de la 
NEDDilación en respuesta al estrés. La importancia de la NEDDilación se ha 
sustentado gracias su inhibidor, MLN4924, usado exitosamente en el tratamiento 
de ciertos tipos de cáncer. En consecuencia, la identificación de nuevos 
sustratos de NEDD8 potencialmente ayudará a ampliar nuestra comprensión 
sobre los mecanismos por el cual su inhibición induce efectos anti-tumorales. No 
obstante, el conocimiento de las proteínas NEDDiladas está muy limitado debido, 
en gran parte, a que las recientes técnicas en espectrometría de masa no 
permiten distinguir entre la NEDDylación y la ubiquitilación ya que ambas 
proteínas liberan la misma señal doble glicina (GG) después de la digestión con 
tripsina del péptido modificado. En este trabajo nos enfocamos en el desarrollo 
de nuevas estrategias aplicadas en proteómica para resolver el problema que 
supone la identificación a gran escala de las proteínas NEDDiladas. Con 
nuestros avances hemos logrado no solo distinguir sustratos específicos de 
NEDD8 sino también los sitios de modificación. Además, por medio de métodos 
de cuantificación en combinación con espectrometría de masas, hemos podido 
caracterizar el papel de la NEDDilación en situaciones de conjugación canónica 
y atípica explorando así más allá de su papel homeostático como regulador de 
las CRLs. 
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ABSTRACT 
 
Protein ubiquitination is an important post-translational modification (PTM) that, 
together with other members of the ubiquitin family (UBLs), is essential for the 
regulation of nearly every aspect of cellular homeostasis. Among all UBLs, 
NEDD8 shares the highest sequence and structure identity with ubiquitin. Despite 
this similarity, a set of NEDD8-specific proteins ensures its own conjugation 
pathway for downstream effects. Cullins represent the main NEDDylation 
substrates. Their modification by NEDD8 results in the activation of ubiquitination 
by favoring alternative conformations of the cullin-RING ligases (CRLs). For a 
long time, cullins were considered the only NEDD8 substrates but recently other 
physiologically relevant NEDD8 substrates have been reported. This suggests 
that NEDDylation controls a more diverse spectrum of biological processes. 
Indeed, a global increase in NEDDylation through the ubiquitin machinery has 
been observed under proteotoxic stress.  However, the role of NEDD8 crosstalk 
with ubiquitin under stress conditions remains unknown. Moreover, the 
importance of protein NEDDylation has been supported by the success of its E1 
enzyme inhibitor, MLN4924, in the treatment of certain types of cancer. 
Therefore, the identification of NEDD8 targets and regulators shows a strong 
potential to define pathways through which the inhibitors exert their anti-tumour 
effects. Nevertheless, there is still a limited knowledge of the non-cullin 
NEDDylation substrates. Identification of specific NEDD8 targets became a 
particular challenge due to knowledge that the overexpression of exogenous 
NEDD8 can trigger NEDDylation by the ubiquitin E1 enzyme UBE1. Furthemore, 
the current proteomics cannot distinguish between NEDD8 and ubiquitin 
modification, as both molecules provide the same diglycine signature on modified 
lysines after trypsin digestion. To overcome these technical barriers, here we 
developed mechanisms to distinguish between the two modes of NEDD8 
activation. We created stable cell lines that express a NEDD8 transgene at 
endogenous levels. Also, we performed mass spectrometry (MS)-based 
proteomics approaches which resulted in the novel proteome-wide identification 
of specific NEDD8 conjugates and modification sites upon different cellular 
conditions. First, by using SILAC-based quantitative proteomics, we could define 
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the dynamic of NEDD8 under proteotoxicity and homeostasis. Secondly, by using 
a mutant form of NEDD8 in protease NEDP1-depleted cells we were able to 
identify up to 1,000 genuine NEDDylation sites. In conclusion, this work presents 
evidence of the broader role of NEDD8 besides CRLs regulation and provides a 
powerful resource to further investigate the apparent complexity of UBLs 
crosstalk during protein modification. 
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ABBREVIATIONS 
 
 
6His 6 times polyhistidine tag 
Ala Alanine (A) 
Apc2 component of the anaphase promoting complex/cyclosome APC/C 
APPBP1 Amyloid beta Precursor Protein Binding Protein 1 (synonym NAE1) 
Arg Arginine (R) 
Asn Asparagine (N) 
Atg autophagy-related ubiquitin-like modifier 
Cas9 CRISPR associated protein 9 
COP9 Constitutive photomorphogenesis 9  
CRISPR Clustered regularly interspaced short palindromic repeats 
CRL Cullin RING ubiquitin ligases 
Cys Cysteine (C) 
DEN1 Deneddylase-1 (synonym NEDP1 and SENP8) 
DMP Dimethyl pimelimidate 
DUBs Deubiquitinating enzymes 
ER Endoplasmic reticulum 
ESI electrospray ionization 
FACS Fluorescence-activated cell sorting 
FAT10 HLA-F-adjacent transcript 10 
FDR False Discovery Rate  
FUBI Fau ubiquitin-like protein 
Gly Glycine (G) 
GO Gene Ontology 
GST Glutathione S-transferase 
HS Heat shock 
HUB1 homologous to ubiquitin 
ICAT isotope-coded affinity tag 
IF Immunofluorescence 
Ile Isoleucine (I) 
ISG15 IFN-induced 15-kDa protein 
iTRAQ isobaric tags for relative and absolute quantification 
KEGG Kyoto Encyclopedia of Genes and Genomes 
KO Knock-out 
LC-MS/MS Liquid chromatography–tandem mass spectrometry 
Lys Lysine (K) 
m/z Mass-to-charge ratio 
MALDI matrix-assisted laser desorption/ionization  
MLN4924 NEDD8-activating enzyme inhibitor (Millenium pharmaceuticals) 
MS Mass spectrometry 
NAE NEDD8 Activating Enzyme 
NAE1 NEDD8-activating enzyme E1 regulatory subunit (synonym APPBP1) 
NEDD8 Neural-Precursor-Cell-Expressed Developmentally Down-regulated 8 
NEDP1 NEDD8 Processing enzyme (synonym SENP8 and DEN1) 
Ni-NTA Nickel-nitrilotriacetic acid 
NUB1 NEDD8 ultimate buster-1 
ON Overnight 
PARC p53 cytoplasmic anchor protein 
PQC Proteins quality control 
PTM Post-translational modification 
RBX1 RING-box protein 1 
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RING Really Interesting New Gene 
RPs Ribosomal proteins 
rRNA Ribosomal RNA 
SCX Strong cation exchanged  
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel electrophoresis 
SENP8 Sentrin-specific protease 8 (synonym NEDP1 and DEN1) 
SILAC Stable Isotope Labelling with Amino acids in Cell culture 
SIMs SUMO.interacting motifs (SIMs) 
STRING Search Tool for the Retrieval of Interacting Genes/Proteins 
STUBLs SUMO-targeted ubiquitin ligases 
SUMO Small Ubiquitin-like Modifier 
TMT tandem mass tags  
TUBEs Tandem Ubiquitin Binding Entities 
Ub Ubiquitin 
UBA Ubiquitin-Associated Domain 
UBA3 NEDD8-activating enzyme E1 catalytic subunit 
UBE1 Ubiquitin-activating enzyme E1 
UBE2F NEDD8-conjugating enzyme UBE2F 
UBE2M NEDD8-conjugating enzyme Ubc12 
UBL Ubiquitin-like protein 
UCHL3 Ubiquitin carboxyl-terminal hydrolase isozyme L3 
UFD Ubiquitin-fold domain 
UFM1 Ubiquitin-fold modifier 1 
UPS Ubiquitin-proteasome system 
URM1  Ubiquitin-related modifier-1 
USP21 Ubiquitin carboxyl-terminal hydrolase 25 
WB Western blotting 
WCE Whole cell extract 
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INTRODUCTION 
 
Besides water, proteins are the most abundant molecules in biology. After their 
biosynthesis by the ribosomes, the majority of proteins are converted into a folded 
compact structure that enables a proper function. These processes are highly 
organized given that a well-functioning cell relies on a efficient regulated 
proteome. (Alam, Siddiqi, Chturvedi, & Khan, 2017). Moreover, all proteins in the 
cell can be covalently modified by small molecules as phosphate, methyl or acetyl 
groups, but also by entire proteins. These called post-translational modifications 
(PTMs) are dynamically reversible and determine different structure, stability, 
activity, localisation and interactions with other cellular molecules without the 
need for changes in de novo protein synthesis (Jensen, 2006). Protein 
modification by ubiquitin and ubiquitin-like proteins (UBLs) have emerged as 
crucial PTMs for the regulation of almost every cellular process (Cipolla, Maffia, 
Bertoletti, & Sabbioneda, 2016).  
 
UBIQUITIN AND UBIQUITIN-LIKE PROTEINS 
 
Ubiquitin is a well conserved small 76 amino acid protein (8.5 kDa) firstly 
described as an ubiquitous abundant protein found in all eukaryotic organisms 
(Schlesinger, Goldstein, & Niall, 1975). In the human genome ubiquitin is 
produced by four different genes: UBB, UBC, UBA52 and RPS27A. Since the 
discovery of ubiquitin in 1975, protein modification by ubiquitin was further 
characterized in the early 1980 by Irwin A. Rose, Avram Hershko, and Aaron 
Ciechanover as a new mechanism for energy-depending intracellular proteolysis. 
This ubiquitin proteolytic model consists of the covalent attachment of ubiquitin 
to proteins to target them for proteasomal degradation and its apparent 
importance was recognized by the attribution of the Nobel prize in Chemistry in 
2004 (Kimura & Tanaka, 2010; Wilkinson, 2005). Nowadays, we know that 
ubiquitin is the founding member of a large family of proteins which contain the 
same β-grasp fold, the so-called ubiquitin-like proteins (UBLs) which their is a 
signal to regulate proteins by modifying their structure, function and/or 
localization (van der Veen & Ploegh, 2012). 
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Ubiquitination 
 
Ubiquitination is the best understood reversible post-translational modification, 
which is well related to a significant number of biological processes appart of its 
essential proteasome-dependent proteolytic role, including cell cycle 
progression, transcriptional regulation, endocytosis, DNA repair, signal 
transduction and transcription. Therefore, deregulation fo this pathway has been 
associated with several pathological conditions such as developmental 
abnormalities, cancer, neurodegenerative disorders, inflammation and immune 
response (Hoeller et al., 2006). The ubiquitination process consists of the 
covalent attachment of ubiquitin to the ε-amino group of lysine residues (Lys) of 
target proteins via its carboxyl-terminal-glycine residue, forming an isopeptide 
linkage in an ATP-dependent reaction. This attachment to substrates is catalysed 
by a hierarchical set of three types of enzymes: ubiquitin-activating (E1), 
ubiquitin-conjugating (E2) and ubiquitin-protein ligase (E3) enzymes (Hershko & 
Ciechanover, 1998). Given that ubiquitin itself contains seven lysines (Lys6, 11, 
27, 29, 33, 48, and 63), it can modify to other ubiquitin molecules which enables 
the formation of polyubiquitin chains with different linkages signal which drives to 
distinct functional outcomes for the tagged proteins (see Scheme 1). As a result, 
the intracellular ubiquitin exists in a dynamic equilibrium among three essential 
forms (i) either as a free monomer, (ii) a substrate-conjugated monoubiquitin or 
polyubiquitin, or (iii) an unanchored ubiquitin chains (Kimura & Tanaka, 2010). 
Deubiquitinating enzymes (DUBs) are ubiquitin-specific proteases which not only 
can reverse the ubiquitination process but also carry the activation of the ubiquitin 
proproteins and the ubiquitin recycle from trapped thiol-ester intermediates and 
polyubiquitin chains. The first two steps of the ubiquitination cascade is triggered 
by few E1 and E2 enzymes but it is estimated that approximately 600 E3s and 
100 DUBs exist in mammalian cells. (Reyes-Turcu, Ventii, & Wilkinson, 2009). 
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Scheme 1. Ubiquitin conjugation 
Ubiquitin (Ub) is a highly conserved 8 kDa protein that becomes covalently attached to 
lysine residues of target proteins in an inducible and reversible manner. This occurs 
through a three-step process involving three different types of enzymes. Ubiquitin is 
activated in an ATP-dependent manner by a ubiquitin-activating enzyme (E1), and is 
then transferred to a ubiquitin-conjugating enzyme (E2) through a thioester bond. A 
ubiquitin-protein ligase (E3) specifically attaches ubiquitin to the ε-amino group of a 
lysine residue in the target protein1. Although only a few E1 enzymes are known, 
humans have more than 20 different E2s. E3 ligases are primarily responsible for 
substrate recognition. To provide specificity about 500–1,000 different E3 ligases exist 
in humans6. After the attachment of a Lys48-linked polyubiquitin chain to a substrate it 
is degraded in the 26S proteasome; the attached ubiquitin moieties can be recycled. 
Ubiquitylation reactions are reversible by de-ubiquitylating enzymes (DUBs), of which 
several types are known at present (Hoeller et al., 2006). 
 
 
Ubiquitn like-proteins 
 
In addition to ubiquitin, mammalian cells encode nearly 20 ubiquitin-like proteins 
(UBLs). Main members of the Ubl family include SUMO-1 to -4 (small ubiquitin- 
like modifier 1 to 4), NEDD8 (neural-precursor cell expressed developmentally 
down-regulated 8), FUBI (Fau ubiquitin-like protein), HUB1 (homologous to 
ubiquitin 1); ISG15 (interferon-stimulated gene); FAT10 (HLA-F-adjacent 
transcript 10), URM1 (Ubiquitin-related modifier-1); UFM1 (Ubiquitin-fold modifier 
1); Atg8 and Atg12 (autophagy-related ubiquitin-like modifier 8 and 12). Most of 
these proteins, do not share a high sequence similarity with ubiquitin (except for 
NEDD8), but they all present a similar three-dimensional structure (the “ubiquitin 
fold” or β-grasp fold) (see Scheme 2) and an analogous modification enzymatic 
cascade. Although all these proteins are structurally related, each one plays 
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different roles in the regulation of protein degradation, subcellular localization, 
activity of the modified protein, among other functions. In this work, we are mainly 
focused on the ubiquitin-like protein NEDD8 therefore its process and regulation 
is further discussed in detail in this instroduction (Kerscher, Felberbaum, & 
Hochstrasser, 2006; van der Veen & Ploegh, 2012).  
 
 
 
Scheme 2. Ubiquitin-like proteins structure 
Structural comparison depicting the conserved β-grasp fold of ubiquitin and Ubl proteins 
(PDB codes: 1UBQ, 1NDD, 1WM3, 1Z2M], and 2KWC). ISG15 has tandem ubiquitin 
folds. The C-terminal glycine of ubiquitin and Ubls is colored red, except for SUMO2 
because it was not or- dered in the crystal structure (Ronau, Beckmann, & Hochstrasser, 
2016). 
 
 
The complex ubiquitn code 
 
Ubiquitin can covalently modify protein substrates by different modes. The 
attachment of a single ubiquitin to one target lysine (on the protein substrate) is 
denominated mono-ubiquitination; and the attachment of several ubiquitin 
molecules on several lysines (on the same target protein) is called multiple mono-
ubiquitination. As mentioned above, ubiquitin itself has seven internal lysines 
where other ubiquitin molecules can be attached and form different poly-ubiquitin 
chains through lysines K6, K11, K27, K29, K33, K48 and K63 (Ikeda & Dikic, 
2008). Moreover, a linear type of ubiquitin chain can be formed through the 
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conjugation of theC-terminal Gly76 of the proximal ubiquitin to the N-terminal 
methione residue of a distal ubiquitin. This linear topology chain is catalyzed by 
a multi-subunit E3 ligase complex termed LUBAC (linear ubiquitin chain 
assembly complex) (Kirisako et al., 2006). Depending on the type of ubiquitin 
modification and the type of linkage whitin the chains, the final distincts signals 
creates the so-called “ubiquitin code” (Scheme 3). This ubiquitin code provides 
diversity in the ubiquitination signal which can be associated with many different 
cellular processes. For example, the best studied poly-ubiquitin chain is the one 
formed through K48 linkages which generally targets the modified proteins for 
proteasomal degradation but also the K11 chains has been associated to 
proteolysis (Ikeda, Crosetto, & Dikic, 2010). Mono-ubiquitination has been 
associated with endocytosis and DNA repair processes whereas the multiple 
mono-ubiquitination is linked to cell surface receptors with subsequent lysosomal 
degradation signal or for the recycling to the cell surface (K Haglund, Di Fiore, & 
Dikic, 2003)Ubiquitin chains through lysine K63 are correlated with proteasome-
independent functions, such as vesicle trafficking, DNA repair and signal 
transduction (Kaisa Haglund & Dikic, 2005). 
 
 
 
Scheme 3. Principles of ubiquitin signalling  
Ubiquitylation is mediated by the sequential activity of a set of enzymes including 
activating (E1), conjugating (E2) and ligating (E3) enzymes. This leads to the conjugation 
of monoubiquitin or polyubiquitin chains of different lengths and link ages to target 
proteins. Depending on the differents types of ubiquitin chains, proteins are subsequently 
degraded via the proteasome or participate in various cell ularfunctions including 
signalling, DNA repair or endocytosis. See text for more details (Fulda, Rajalingam, & 
Dikic, 2012) 
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Unquestionably, the ubiquitin code is more complex that expected. There are new 
ways the ubiquitin moifications can be classified. For example, mono-
ubiquination can occur with an unmixed or a modified ubiquitin, chains can be 
from one linkage type (homotypic) or different linkage type (heterotypic) 
(Komander & Rape, 2012).  Furthemore, chains of one linkage type can be 
extended by a second type, forming a mixed non-branched structure but when a 
ubiquitin molecule in a chain is ubiquitinated at various lysines this forms a 
“branched” or “forked” structure. Moreover, it has been recently showed that 
ubiquitin can be also modified by other UBLs including SUMO and NEDD8, and 
other PTMs such as phosphorylation and acetylation (Swatek & Komander, 
2016). These alternative modifications increase the potential for unlimited 
number of combinations. Besides, non-attached (or unanchored) ubiquitin or 
ubiquitin chains exist in cells which leads to second-messenger-like functions 
(Swatek & Komander, 2016; Xia et al., 2009) (Scheme 4).  
 
 
 
Scheme 4. New complexity in the ubiquitin code 
(A) Conceptual representation of some of the possible ubiquitin-, Ubl (NEDD8, 
SUMO2/3)- and chemical modifications of ubiquitin. (B) Unanchored ubiquitin and 
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ubiquitin chains, with or without modifications, can function as second messengers in 
cells (Swatek & Komander, 2016). 
 
 
Ubiquitin binding motifs as decoders 
 
Ubiquitin modification of substrates is decoded by specific receptors containing 
ubiquitin- binding domains (UBDs). Several types of UBDs have been identified 
that differ in their structure and mode of interaction with ubiquitin. UBDs can be 
classified into four major subfamilies: those containing single or multiple α-
helices, zing-fingers, a pleckstrin-homology (PH) fold and ubiquitin-conjugating-
like structures. Despite their differences, they all bind non-covalently to mono and 
polyubiquitin to decode and translate the ubiquitin signal into the corresponding 
cellular fate (Ikeda et al., 2010). Most UBDs bind monoUbiquitin via the 
hydrophobic patch around Isoleucine 44. The binding affinities of individual UBDs 
for Ubiquitin are normally low. Nevertheless, in the cell, this affinity of interaction 
can be increased by the presence of several UBDs in the same receptor or even 
multiple Ubiquitin-binding surfaces within a single UBD. In fact, most Ubiquitin-
receptors are known to contain different UBDs (Husnjak & Dikic, 2012). In 
addition to their interaction with monoubiquitin, many UBDs present high 
selectivity for precise Ubiquitin-linkages. This selectivity is ensured either by the 
recognition of the linkage between two Ubiquitin or by the detection of the spatial 
distribution of the Ubiquitin moieties (Dikic, Wakatsuki, & Walters, 2009). Among 
Among the different types of UBDs, the most common have single or multiple α-
helices, like the Ubiquitin-associated domain (UBA) and the ubiquitin-interacting 
motif (UIM). In fact, UBA domains are found in many effectors of the Ubiquitin-
proteasome system like the shuttle factors Rad23, PLIC1-2 (DSK2) that deliver 
Ubiquitinated substrates to the 26S proteasome (Funakoshi et al., 2002; 
Hofmann and Bucher, 1996; Rao and Sastry, 2002). In addition, P62 that ensures 
the degradation of Ubiquitinated substrates by the autophagic pathway also 
contains a UBA domain (Isogai et al., 2011). UBA domains normally show 
preference for K48-linked chains (Raasi and Pickart, 2003; Wilkinson et al., 
2001). An example of other Ubiquitin-interacting proteins with UBDs is 
Rpn10/S5α and Rpn13; both are intrinsic receptors of the proteasome containing 
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UIM and the Pleckstrin-homology (Pleckstrin-like receptor for Ubiquitin (PRU)) 
domains respectively (Husnjak et al., 2008; Riedinger et al., 2010). The DNA-
double strand break response protein (RAP80) harbours two UIM domains and 
interacts preferentially with K63-linked chains due to the length of the linker 
region between these two UIMs (Sims and Cohen, 2009). To increase the 
diversity of the Ubiquitin signalling, a Ubiquitin-Like Fold (UBL) can be also found 
either in Ubiquitin-Like Molecules that share the same Ubiquitin fold and can be 
conjugated to substrates, or as a part of a multidomain structure in proteins that 
cannot be conjugated to substrates. As an example of the second type of 
proteins, shuttle factors use their UBDs to bind Ubiquitinated substrates and then 
interact with the proteasome via their UBL domains, thus allowing substrate 
transfer for degradation (Miller and Gordon, 2005; Welchman et al., 2005). 
 
 
PROTEIN NEDDYLATION 
 
Among all UBLs identified to date, NEDD8 (neural precursor cell expressed 
developmentally downregulated protein 8) shares the highest amino acid identity 
(60%) and homology (80%) with ubiquitin (T. K. Kamitani, Kito, Nguyen, & Yeh, 
1997). NEDD8 is a conserved, mostly nuclear protein that consist of 81 amino 
acid residues which was first discovered as one of the ten NEDD genes that are 
down-regulated in mouse brain during development (Kumar, Tomooka, & Noda, 
1992; Whitby, Xia, Pickart, & Hill, 1998). NEDDylation showed to be essencial for 
the viability of most model organisms with a particular exception of S.cerevisiae 
(Rabut & Peter, 2008). As expected from the high level of sequence conservation, 
the structure of NEDD8 closely resembles that of ubiquitin. Nevertheless, the 
small differences in their sequences/structures can mediate distinct interactions 
that allow their specific functions in cells. In the sequence level, biochemical 
analyses have demonstrated that Ala72 of NEDD8 (Arg72 in ubiquitin), performs 
a key role in preventing the interaction of NEDD8 with the ubiquitin E1 enzyme 
(Whitby et al., 1998). In the overall structure level, NEDD8 and ubiquitin 
conserved several important properties. For example, two surface-exposed 
hydrophobic patches on ubiquitin (Ile44 and Ile36 patches) have been shown to 
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be essential for mediating protein–protein interactions although both are 
conserved in the NEDD8 structure. The largely conserved region in NEDD8 
known as the β1–β2 loop is another functional important region conserved in 
ubiquitin. However, the intermediary polar and charged surfaces are less 
conserved between ubiquitin and NEDD8. These last features presumably 
influence their distinct functions, leading to specific NEDD8-binding proteins for 
downstream effects (Enchev, Schulman, & Peter, 2014; Whitby et al., 1998) (see 
Scheme 5)  
 
 
 
Scheme 5. NEDD8 structure 
a) Structure-based multiple sequence alignment of NEDD8 (neural precursor cell 
expressed developmentally downregulated protein 8) from indicated species (Homo 
sapiens, Mus musculus, Drosophila melanogaster, Caenorhabditis elegans and 
Saccharomyces cerevisiae) and of human ubiquitin, highlighting identical residues (red) 
and similar residues (yellow). Asterisks signify residues found to be essential for NEDD8 
function in the fission yeast Saccharomyces pombe64. b) Structural representation of 
the NEDD8 hydrophobic patches, which contribute most of the known interfaces for 
interaction with binding partners. The side chains contributing to the Ile36 patch are 
shown in blue, the residues of the Ile44 patch in green and the β1–β2 loop in red. These 
interfaces are conserved in ubiquitin. Ala72, which is responsible for discrimination 
between NEDD8 and ubiquitin by the respective E1 enzymes, is also shown. c, d) 
Structural representations of the NEDD8-specific charged surface patches. Acidic 
patches are depicted in red and basic surfaces in blue on two views of NEDD8, rotated 
180° around the y axis. These surfaces might be responsible for interactions that 
discriminate between NEDD8 and ubiquitin (Enchev et al., 2014). 
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The NEDDylation cascade 
 
Despite this similarity, NEDD8 has its own set of enzymes to ensure a distinct 
conjugation pathway. UCHL3 (ubiquitin carboxyl-terminal hydrolase isozyme L3) 
is a cysteine (Cys) protease that removes the C-terminal extensions of both 
ubiquitin and NEDD8 precursors. A second Cys protease, known as 
NEDP1/DEN1/SENP8, has high specificity for NEDD8 and not for ubiquitin. Both 
enzymes can expose the NEDD8 diglycine motif through which the E1 complex 
APPBP1–Uba3, also known as NEDD8-activating enzyme (NAE), the E2s 
UBE2M (Ubc12) or UBE2F (NEDD8-conjugating enzymes) and multiple NEDD8-
E3s ligases ensures the covalent modification of NEDD8 through an isopeptide 
bond to a Lys residue in the target protein. Most of the reported NEDD8 E3 
ligases have shown dual specificity for NEDD8 and ubiquitin, such as the p53-
negative regulator MDM2, c-CBL, SMURF1, IAPs, and RBX1/2. The only clear 
exception is DCN1 which is a NEDD8-specific ligase known to enhance cullin 
NEDDylation. The reversible de-NEDDylation process is carried out either by the 
multi-component COP9 signalosome, the protease NEDP1 or the ubiquitin 
protease USP21 (Enchev et al., 2014; Rabut & Peter, 2008; D. Xirodimas, 2008) 
(see Scheme 6). The COP9 signalosome complex, a zinc metalloproteinase, has 
a particular low affinity for NEDD8 but is highly specific to de-NEDDylate cullins. 
The protease USP21 was reported to be able to deconjugate both ubiquitin and 
NEDD8 showing more specificity towards ubiquitin. Interestingly, NEDP1 has an 
insignificant activity when it comes to deconjugating a single NEDD8 from cullin 
substrates. However, NEDP1 is more active in the de-NEDDylation of hyper-
NEDDylated cullins, resulting in mono-NEDDylated substrates, which indicates 
that it might prevent the formation of poly-NEDD8 chains and that it is implicated 
in the regulation of cullin-independent substrates (Chan et al., 2008; Cope & 
Deshaies, 2003; Ye et al., 2011).Besides the de-NEDDylating enzymes, the 
protein levels of NEDD8 and NEDDylated substrates are also negatively 
regulated by cellular factors such as NUB1 (NEDD8 ultimate buster-1). NUB1 can 
interact with NEDD8 and promote the proteasomal degradation of NEDD8 and 
its protein conjugates (T. Kamitani, Kito, Fukuda-Kamitani, & Yeh, 2001).  
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Scheme 6. Neddylation pathway 
Schematic representation of the main steps of the neddylation pathway, including 
NEDD8 precursor processing, activation by the E1 (UBA3–APPBP1 
heterodimer), loading onto the E2 (Ubc12), conjugation to a substrate by an E3 
and recycling of NEDD8 by an isopeptidase. APPBP1, APP binding protein 1; 
NEDD8, neural precursor cell expressed developmentally downregulated protein 
8; UBA3, ubiquitin-like modifier activating enzyme 3; Ubc, ubiquitin-conjugating 
(Rabut & Peter, 2008) 
 
 
NEDD8 substrates 
 
The best characterized substrates for NEDD8 are the cullin family members. 
Therefore, the NEDDylation targets are essentially classified in two groups: 
cullins and non-cullins. The cullin family is composed by Cul1, 2, 3, 4A, 5 and 7. 
Moreover, PARC (p53 cytoplasmic anchor protein) and Apc2 (component of the 
anaphase promoting complex/cyclosome APC/C) proteins posses the cullin 
homology domain. All cullins are NEDDylated except for Apc2 which lacks the 
lysine consensus motif for NEDDylation and still the NEDDylation of Cul7 is 
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unclear (Jones et al., 2008; Pan, Kentsis, Dias, Yamoah, & Wu, 2004). Cullins 
are scaffold proteins necessary for the dynamic assembly of the ubiquitin ligase 
complexes called Cullin-RING ligases (CRLs). Different types of CRLs can be 
formed using the distinct cullins. The essential complex consists of a cullin protein 
that interacts with a RING finger protein (RBX1 or RBX2) at its C-terminus and 
with a substrate receptor (directly or via an adaptor) at its N-terminus. The 
RBX1/2 proteins catalyse the ubiquitination of the CRL substrates by its binding 
with the ubiquitin-loaded E2. The NEDDylation of cullins enhance the 
ubiquitination process of CRLs by favouring alternative conformations of the cullin 
C-terminal domain and consequently of the bounded RBX protein (Lydeard, 
Schulman, & Harper, 2013) (see Scheme 7). The regulation of this CRL-
NEDDylated mechanism is mainly regulated by the Cop9 signalosome (CSN) 
complex and the exchange factor CAND1 (cullin-associated NEDD8-dissociated 
protein 1). The CSN complex mediated the deNEDDylation of cullins so then 
CAND1 can bind to the cullin protein which triggers the substrate-specifc 
receptors exchange (Zemla et al., 2013). 
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Scheme 7. Architecture of human cullin–RING E3 ubiquitin ligase system 
The number of human SRs for each CRL complex is indicated on the left. CUL4A and 
CUL4B are represented as a single CRL. The CRL regulatory apparatus is composed of 
the neddylation system, the deneddylation system and the SR-exchange factor. UBC12 
is the neddylation E2 for RBX1-based CRL complexes, whereas UBE2F is the E2 for 
CRL5–RBX2. DCN1 is a co-E3 for both RBX1 and RBX2. The CSN deneddylates CRLs. 
CAND1 is a CRL exchange factor that interacts with both the amino- and carboxy-
terminal regions of the cullin–RING complex. CSN subunits are indicated, an asterisk 
indicates that CSN5 is the catalytic subunit. CRL, cullin–RING E3 ubiquitin ligase; CSN, 
COP9 signalosome; N, NEDD8; S, substrate; SR, substrate receptor; U, ubiquitin 
(Lydeard et al., 2013).  
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Proteomic approaches have identified several non-cullin NEDD8 substrates that 
participate in many important cellular processes such as: p53, p73, BCA3, pVHL, 
EGFR, Mdm2 and ribosomal proteins suggesting that the NEDD8 proteome is 
more diverse than previously thought.(Jones et al., 2008; D. P. Xirodimas et al., 
2008). The NEDDylation of p53 and ribosomal proteins are some of the best 
characterized non-cullin substrates. NEDDylation of p53 is ensured by the 
ubiquitin and NEDD8 E3 ligase Mdm2 but also by FBXO11, a member of the F-
box protein family and a component of the cullin1 RING ligase. The NEDDylation 
increases the stability of p53 but inhibits its transcriptional activity (Abida, 
Nikolaev, Zhao, Zhang, & Gu, 2007; D. P. Xirodimas, Saville, Bourdon, Hay, & 
Lane, 2004). Even that p53 is a common substrate for both NEDD8 and ubiquitin, 
it is differentially controlled by these two modifiers. A fusion of NEDD8 to the C-
terminus of p53 causes its nuclear localisation while a ubiquitin fusion relocalises 
it to the cytosol (Brooks & Gu, 2006). In addition, NUB1 was shown to inhibit p53 
NEDDylation, stimulate its monoUbiquitination and thus mediate its cytoplasmic 
localisation (Liu and Xirodimas, 2010). Moreover, Tip60 acetyltransferase was 
shown to exclusively blocks Mdm2-mediated p53 NEDDylation and not 
ubiquitination (Dohmesen et al., 2008). Mdm2 also NEDDylates TAp73 (p53 
homologue) causing an inhibition of its activity. But in contrast to p53, 
NEDDylated p73 localizes to the cytosol (Watson et al., 2006). Ribosomal 
proteins (RPs) have emerged as important targets of NEDD8 (Xirodimas et al., 
2008). For example, NEDDylation of RPL11 by Mdm2 increases its stability and 
mediates its nucleolar localization. However, upon nucleolar stress caused for 
example by low doses of Actinomycin D, NEDDylation of RPL11 decreases, thus 
allowing its re- localization into the nucleoplasm. By binding Mdm2, RPL11 
represses Mdm2-mediated ubiquitination of p53, therefore ensuring p53 
stabilization and transcriptional activation in response to stress (Mahata et al., 
2012; Sundqvist et al., 2009). 
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MASS SPECTROMETRY- BASED PROTEOMICS  
 
The human genome can generate hundreds of thousands of different gene 
products. Nevertheless, the result of allelic variations, mRNA splicing, protein 
processing and post-translational modifications (PTMs) make proteomes 
significantly more complex than genomes and transcriptomes in their molecular 
heterogeneity and diversity. Site-specific covalent modifications, such as 
phosphorylation, acetylation and ubiquitination, can regulate protein structure 
and function in real-time dynamic manner. In general, PTMs creates a molecular 
code that delivers protein conformation, cellular location, macromolecular 
interactions and activities, depending on the cell type, the tissue and the 
environmental conditions. These reversible modifications are implicated in a wide 
variety of cellular processes, including transcription, replication, cell-cycle 
progression, and responses to DNA damage. Therefore, protein PTMs has 
become an important study for the biological and biomedical areas (Jensen, 
2006; Vertegaal, 2011). The goal of large-scale proteome analysis (proteomics) 
is to be able to elucidate this molecular and functional plasticity of proteins by 
mapping and dynamically quantifing PTMs. The rapid evolution of proteomics is 
due in large part to many improvements in mass spectrometry (MS) during the 
past 10 years (Parker, Warren, & Mocanu, 2010). MS-based proteomics 
englobes the advances in many technical areas such as affinity enrichments, 
protein quantitation, the availability of gene and genome sequence databases, 
the discovery and development of protein ionization methods and bioinformatic 
analysis (bioinformatics) (Aebersold & Mann, 2003; Jensen, 2006). Given the 
ability of MS-based proteomics to precisely identify and quantify complex 
proteomes from samples, nowadays it becomes the indispensable tool from 
molecular, cellular and systems biology. The advances include the 
characterization of protein-protein interactions, large-scalse identification of 
substrates and modification sites and the generation of quantitative protein 
profiles from different organelles within human cells or diverse species 
(Aebersold & Mann, 2003).  
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MS overview and workflow 
 
The basic of mass spectrometers is to measure mass. The measurement of the 
mass is dependet of its gas-phase ions behaviour in an electromagnetic field 
which provides information on the protein identity, its chemical modification, and 
its structure. A mass spectrometer consists in three main components: (i) an ion 
source from charged species, (ii) a mass analyser that separate ionized analytes 
based on their mass (mass-to-charge ratio, m/z), and (iii) a detector that register 
the number of ions at each m/z to give a measurable signal (Aebersold & Mann, 
2003; Zee & Garcia, 2012). The first m/z measurement of the ionized peptides is 
called the MS1 step. Then, each ion is sequencially isolated, fragmentated 
(chemical bonds break) and measured again to produce a final “fragmentation 
spectra” or also called tandem mass spectrum (MS2 or MS/MS) (Hennrich & 
Gavin, 2015). There are two main ionization techniques: electrospray ionization 
(ESI) and matrix-assisted laser desorption/ionization (MALDI). ESI technique is 
immediately linked to liquid-based separation tools, such as chromatography and 
electrophoresis, due to is ability to ionized peptides from a solution. In contrast, 
MALDI uses laser pulses to vaporise and ionize the samples in a dry crystalline 
matrix. Therefore, MALDI-MS is frequently applied for the analysis of relatively 
simple peptide mixtures, whereas liquid-chromatography ESI-MS procedure (LC-
MS) are preferred for complex samples (Aebersold & Mann, 2003). Current MS-
based proteomics is mainly using a general workflow for the proteome and PTM 
analysis in complex samples. This “shotgun” proteomics approach basically 
consist in four sections: (i) proteome extraction, enzymatic digestion and specifc 
enrichment (ii) peptide separation and ionization by liquid chromatografy, (iii) 
mass spectra fragmentation and (iv) mass spectrum analysis (Choudhary & 
Mann, 2010; Sylvestersen, Young, & Nielsen, 2013) (see Scheme 8) 
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Scheme 8. Typical workflow for proteome and PTM analysis using shotgun 
proteomics 
a | Proteins extracted from organs, tissues or cells are separated by one-dimensional 
polyacrylamide gel electrophoresis (1D PAGE) and 'in-gel digested' into peptides using 
proteases such as trypsin. The peptides containing specific post-translational 
modifications (PTMs) can be enriched using different approaches. Non-modified 
peptides are used to identify and quantify total cellular proteins. b | Purified peptides are 
separated on a miniaturized reverse phase chromatography column with an organic 
solvent gradient. Peptides eluting from the column are ionized by electrospray at the tip 
of the column, directly in front of the mass spectrometer (known as on-line coupling). c | 
The electrosprayed ions are transferred into the vacuum of the mass spectrometer. In 
the mass spectrometry (MS) mode, all ions are moved to the orbitrap mass analyser, 
where they are measured at high resolution (top mass spectrum). The first mass analyser 
then selects a particular peptide ion and fragments it in a collision cell. The inset in the 
MS panel indicates the stable isotope labelling by amino acids in cell culture (SILAC) 
ratio of one of the peptides. The MS/MS spectrum can be obtained in the ion trap mass 
analyser at low resolution or in the orbitrap at high resolution. For modified peptides, the 
peptide mass will be shifted by the mass of the modification, as will all fragments 
containing the modification, allowing the unambiguous placement of the PTM on the 
sequence. d | The mass and list of fragment masses for each peptide are scanned 
against protein sequence databases, resulting in a list of identified peptides and proteins. 
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These lists of proteins and their quantitative changes are the basis for biological 
discovery (Choudhary & Mann, 2010).  
 
 
SILAC-quantitative proteomics 
 
Proteome quantification has become the best strategy to understand post-
translational modification dynamics. Accurate quantitative MS-based proteomics 
techniques are essential due to the inherent nonquantitative aspect of MS. The 
limitations of MS quantitation come from the several physicochemical properties 
of the proteolytic resulted peptides such as size, charge and hydrophobicity which 
give rise to variable mass spectrometric responses. Therefore, in MS it is not 
possible to compare the relative abundance changes from different experimental 
samples. This issue can be overcome by the introduction of stable isotopes into 
the proteins which reduce the variability from sample injection and ion 
fragmentation by mass spectrometers in different MS runs and hence, allows the 
quantification from different samples in the same MS analysis (X. Chen, Wei, Ji, 
Guo, & Yang, 2015). There several procedures for MS-based quantitative 
proteomics which can be grouped in three categories: (i) chemical/enzymatic 
labelling, (ii) metabolic labelling, and (iii) label-free. Chemical/enzymatic labelling 
methods includes isotope-coded affinity tag (ICAT), isobaric tags for relative and 
absolute quantification (iTRAQ), tandem mass tags (TMT), dimethyl-labeling, and 
18O labelling whereas for the metabolic labelling procedures is used biological 
the incorporation of stable isotope labels such as SILAC (stable isotope labeling 
by amino acids in cell culture) and 15N labeling. In contrast, label-free methods 
compare samples by measuring the ion intensity changes or by spectrum 
counting which consist of counting the number of fragment spectra of the 
peptides identified of a particular protein (X. Chen et al., 2015; Hennrich & Gavin, 
2015). The SILAC technique was first used in 2002 (S.-E. Ong et al., 2002) and, 
so far, this method posses the most advantages for quantitation over the other 
labeling approaches. SILAC can be used for study extensive sample processing 
such as subcellular fractionation, affinity purification or enrichment of peptides 
with PTMs. The major disadvantage of SILAC is that because of the limited 
labeling combinations available, few different cellular states can be compared. 
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Nevertheless, so far is the best method used for quantitative proteomics because 
its great compatibility, quantitative reliability, and practical implementation (S. E. 
Ong, 2012). The SILAC workflow can be divided in two phases: (i) the adaptations 
phase and, (ii) the experimental phase (see Scheme 9). As a general view, SILAC 
metabolically incorporates stable isotope labelled amino acids, such as 13C or 
15N-labeled arginine or lysine, into the entire cells proteome. This incorporation 
is drived to the innate proteins metabolism happening during cell culturing. Thus, 
the basic incorporation method give rise to two populations, (i) the “light” medium 
containing amino acids with the natural isotop, and (ii) the “heavy” medium 
containing the isotope labelled amino acids. For a complete labeling (at least 
>95% labeling efficiency), at least five cell division cycles are needed for 
mammalian cells but this can vary whitin cell lines depending on the rate of 
protein synthesis, degradation, and turnover. Once cells are totally incorporated 
with the respective isotopes then cells are experimentally manipulated and mixed 
resulted protein extracts in equal amounts for further enzymatic digestion. The 
digested peptides are analysed with LC-MS/MS for protein quantification which 
is based on the ratio of “heavy” isotope-labeled peptides to the “light” unlabeled 
peptides. The intensities of the ligh and heavy signals enable the quantitative 
comparison of the proteins relative abundance in the proteome sample mixture 
(X. Chen et al., 2015; Mann, 2006) 
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Scheme 9. Workflowfor quantitative proteomic experiments using SILAC 
The SILAC experiment consists of two phases: an adaptation phase (A) and an 
experimental phase (B). (A) During the adaptation phase, cells are grown in light and 
heavy SILAC media for several cell divisions un- til full incorporation of the heavy amino 
acids in the growing cells. The degree of SILAC amino acids incorporation can be 
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evaluated byMSanal- ysis. Depending on the study design, a triple strat- egy using light, 
medium, and heavy labeling can be used. (B) During the experimental phase, after the 
full incorporation of SILAC amino acids was confirmed, the cells populations are 
experimen- tally manipulated. Subsequently, the cells popu- lations or protein lysates 
aremixed depending on the study. For sub-proteome analysis, cells pop- ulations are 
combined for organelle prefraction- ation; and for expression proteomics, interaction 
proteomics or PTMomics, the extracted protein lysates are mixed. After digestion of the 
SILAC- labeled proteins into peptides, peptides are then analyzed with LC-MS/MS. The 
identification and quantification of peptides is accomplished with quantitation software 
such as MaxQuant. In case of investigating protein–protein interaction, pro- tein 
complexes are immuno-precipitated from the mixture of SILAC-labeled cell lysates. For 
PTMomics analysis, SILAC labeling peptides are subject to a fractionation and an 
enrichment step to improve identification of PTM-peptides (X. Chen et al., 2015).   
 
 
Proteomics for ubiquitinated sites 
 
The ubiquitin remnant profile is the most efficient proteomic strategy use for the 
large-scale identification of ubiquitination sites. Trypsin digestion is the proteolytic 
step tipically used for the MS identification of ubiquitinated residues. This 
disgestion is able to cleave all the ubiquitin molecule with an exception for the 
last two C-terminal glycine residues of ubiquitin which remains covalently linked 
to the lysine residue of the target protein. Therefore, this tryptic digestion releases 
a signature called the diglycine remnant or di-Gly motif. The diglycine remnant 
itself gives a peptide mass shift of ∼114 Da which can also be detected in the 
MS/MS spectrum as a mass difference corresponding to the diglycine 
modification. Indeed, the first large-scale ubiquitination analysis was performed 
using this 114 Da mass shift approach and allowed the identification of around 
100 ubiquitination sites in yeast (Peng et al., 2003). This finding give rise to the 
rapid improvement of the MS instrumentation by speed and sensitivity and 
therefore up to 1000 sites where achieved using this approach (Shi et al., 2011).  
The disadvantage of this strategy was that even with the enrichment of 
ubiquitinated proteins by using a epitope tagged ubiquitin reduces the complexity 
of the analyzed sample, the amount of peptides possessing the diglycine remnant 
was predominantly low. In consequence, the studies were mainly supported by 
the sensitivity and capability of the mass spectrometers. An important innovation 
of the ubiquitination proteomics was done in 2010 by Xu et al. during the 
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development of the monoclonal antibody GX41 that presented a great specificity 
for the diglycine adducts on the targeted lysines. Then, the workflow for the 
analysis consisted in the trypsin proteolysis of the sample, enrichment of the 
diglycine-modified peptides by using the specific digycline lysine antibodies for 
the further analysis by LC-MS/MS (Scheme 10). This new enrichment advantage 
together with the advances in high resolution mass spectrometry allowed the first 
proteome-wide identification of thousands of endogenous ubiquitination sites in 
human cells (Kim et al., 2011; S. a. Wagner et al., 2011). Some of the limitations 
of the antibody enrichment is its low sensitivity for identified lower expressed 
modified proteins as is mainly identifiying more abundant proteins. Moreover, 
antybodies itself also exhibits slight peptide sequence preferences and this can 
create a great variation between studies. In fact, this was the case for the 
analyses done by Kim et al, and Wagner et al. where even they identified more 
than 23, 000 ubiquitination sites by using the same diglycine antibody, only 4300 
sites were common between experiments. Moreover, the two databases also 
presented different preferences for certain amino acids adjacent to the identified 
lysine site (Sylvestersen et al., 2013). Interestingly, this antibody-sequence 
preference observation was confirmed with a recent study that compared two 
different diglycine antibodies in murine tissues (Sebastian a. Wagner et al., 
2012). Nevertheless, the novel techniques in the discovery of ubiquitination sites 
reveal its importance and demonstrated that ubiquitination is occurring 
abundantly in the cell in a similar way as the phosphorylation and acetylation.  
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Scheme 10. Enrichment of K-ε-GG peptides using anti–K-ε-GG antibody 
After the antibody has been chemically cross-linked to a protein A bead using DMP, 
peptides are individually enriched for K-ε-GG peptides using the anti–K-ε-GG antibody, 
which recognizes the di-glycyl remnant remaining on modified lysine residues after 
trypsin digestion (Udeshi, Mertins, Svinkina, & Carr, 2013). 
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MATERIALS AND METHODS 
 
Reagents 
• gRNA-NEDP1-pCas9-GFP vector (Sigma-Aldrich) 
• Lipofectamine RNAiMAX (Invitrogen) 
• Lysyl endopeptidase (Endoproteinase Lys-C; Wako) 
• MG132 (Viva Bioscience) 
• MLN4924 (Millenium Pharmaceuticals - Takeda) 
• Nickel-nitrilotriacetic acid (Ni-NTA) agarose (Qiagen) 
• Protease Inhibitor Cocktail Tablets EDTA-free (Roche)  
• PTMScan£ ubiquitin branch motif (K-ε-GG) immunoaffinity beads (K-ε-
GG antibody conjugated to protein A agarose beads; Cell Signaling 
Technology) 
• Sequencing Grade Modified Trypsin (Promega) 
• SILAC labelled amino acids (Euriso-Top) 
• siRNA On-TARGETplus SMARTpools (Dharmacon) 
 
Primary antibodies 
Name Species Dilution Source 
NEDD8 (Y297) Rabbit 
1:150 (IF) 
1:2000 (WB) 
GeneTex 
SUMO-2/3 Mouse 
1:200 (IF) 
1:2000 (WB) 
In house 
Ubiquitin (FK2) Mouse 1:150 (IF) Viva Bioscience 
Ubiquitin  Rabbit 1:2000 (WB) DAKO 
GAPDH (C65) Mouse  1:1000 (WB) Abcam 
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H2A Rabbit 1:1000 (WB) Abcam 
RPL7 Rabbit 1:2000 (WB) Abcam 
α-tubulin  Mouse  1:1000 (WB) Cell Signaling 
p53 (DO-1) Mouse 1:1000 (WB) In house 
PCNA (PC10) Mouse 1:1000 (WB) Millipore 
NEDP1 Sheep 1:1000 (WB) In house 
APPBP1 Mouse 1:1000 (WB) Abnova 
H2B Rabbit 1:1000 (WB) Millipore 
 
Cell culture 
 
With the exception of H1299 lung carcinoma cells cultured in RPMI medium the 
rest of cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and standard antibiotics 
(Penicillin, 50 U/ml and Streptomycin 50µg/ml) in 5% CO2 at 37oC in a humidified 
incubator. Cells stably expressing 6His-NEDD8WT or 6His-NEDD8R74K were 
cultured in the presence of 2.5µM puromycin for selection.  
 
CRISPR/CAS9 
 
U2OS and HCT116 cell lines were transfected with 6 µg of gRNA-NEDP1-pCas9-
GFP vector (Sigma-Aldrich), respectivley. 24 hrs transfection cells were 
subjected to fluorescence-activated cell sorting (FACS) to isolate cell populations 
with significantly increased frecuencies of Cas9-induce modifications (sorted into 
fractions with low, medium, and high GFP expression levels). Cell clones were 
tested for NEDP1 depletion by immunoblot analysis. The best NEDP1 KO clones 
were selected for the experiments. 
 
 37 
Generation of stable cell lines by lentivirus based approach 
 
6His-NEDD8WT
 
and 6His-NEDD8R74K
 
respectively were cloned into lentivirus 
vector. 293T cells were seeded in 10cm cell-culture dishes at 5x106
 
cells per 
plate in DMEM with 10% FBS. Next day, 1.5μg of transfer plasmid (lentiviral 6His-
NEDD8WT
 
or 6His-NEDD8R74K) was mixed with 1μg of packaging construct 
(pCMV) and 1μg of envelope plasmid (pMDG). Transfections were performed 
using Fugene6 HD (Roche) transfection reagent according to the manufacturer's 
instructions. Medium was replaced with DMEM with 10% FBS the next day. 
Supernatant was harvested 2 and 3 days post-transfection, filtered through a 
0.45μm pore-size filter (Sartorius, Minisart), and stored at -80ºC.  
 
For generating stable cell lines, HCT116 and U2OS cells, respectively, were 
seeded in 6-well plate at 40x104
 
cells per well in DMEM with 10% FBS. 200μl of 
the lentiviral supernatant was added to the cells in the presence of 10μg/ml 
polybrene. Medium was replaced with DMEM with 10% FBS the next day. 3 days 
post-infection, puromycin was added to the medium at 5μg/ml. The stable cell 
line was maintained in the medium with 2.5μg/ml of puromycin and the 
expression of 6His-NEDD8 was tested monthly.  
 
Transfections 
 
Cells were seeded in 6-well plates or 10cm dishes to the desired confluency. 5nM 
of siRNA was transfected with Lipofectamine RNAiMAX according to 
manufacturer’s instructions. Non-target siRNA was used in control transfections. 
For the SILAC experiment transfections were performed in 6-well plates and 6hrs 
later cells were combined and reseeded in 10cm dishes. Cells were harvested 
48hrs post-transfection.  
 
Subcellular fractionation 
 
After the appropriate treatment, cells in 10cm culture dish were washed twice with 
ice cold PBS, then scrapped into 1ml PBS. 100µl of cells were pelleted at 
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13000rpm for 1min and lysed with the appropriate volume of 2xSDS loading 
buffer. The remaining 900µl of cells were pelleted at 10800rpm for 20s. Cell pellet 
was resuspended in 300µl buffer A (10mM HEPES-KOH pH 8.0, 10mM KCl, 
1.5mM MgCl2) with protease inhibitor and 10mM iodoacetamide. Cells were lysed 
by adding Triton-X100 at a final concentration of 0.1% for 1min at 4oC, then spun 
for 5min at 1300g 4oC. The supernatant (cytoplasmic fraction) was mixed with 
equal volume of 2xSDS. The pellet (nuclear fraction) was washed 3 times with 
buffer A, then resuspended with 300µl of buffer B (20mM HEPES-KOH pH 8.0, 
300mM NaCl, 2mM EDTA and 1%NP40) and incubated 30min on ice. Lysates 
were sonicated on ice, 8x30s with 50% amplitude (Branson Digital Sonifier) and 
centrifuged at 13000 rpm for 15min. The supernatant (nucleoplasmic fraction) 
was mixed with equal volume of 2xSDS, and the pellet (pellet fraction) was 
washed 3 times with buffer B then resuspended in 2xSDS.  
 
BCA protein assay  
 
Protein concentration was measured by BCA Protein Assay (Thermo scientific). 
Reagent A and reagent B were mixed in 50:1 volume ratio. 8μl of each sample/or 
the lysis buffer (Blank) were added to 1ml of the BCA mix and incubated at 60ºC 
in a water bath until the color became light purple (30min). Tubes were left to cool 
down back to room temperature and the absorbance was measured by 
spectrophotometer at OD562. The protein concentration was determined from a 
standard curve using BSA.  
 
Western blot analysis  
 
Proteins were resolved in sodium dodecyl sulphate (SDS) polyacrylamide 
electrophoresis (SDS-PAGE) gels and transferred onto PVDF membrane using 
the Bio-Rad Mini Trans-Blot apparatus. Membranes were blocked in 5% milk 
solution (PBS with 0.1% Tween-20 and 5% skimmed milk) for 1hr at room 
temperature with gentle agitation. Membranes were incubated with the primary 
antibodies overnight at 4oC. Primary antibodies were diluted in TBS 0.1% Tween-
20 with 3% BSA and 0.1% NaN3. Membranes were washed 3x10min with PBS 
0.1% Tween-20 and then incubated with the appropriate secondary antibody 
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(Sigma Aldrich) for 1hr at room temperature (5% milk). After incubation, 
membranes were washed 2x15min with PBS 0.1% Tween-20 followed by 2x5min 
with PBS. Detection was performed with ECL Western Blotting Detection 
Reagents and membranes were exposed to X-ray Medical Film before being 
developed. 
 
Synchronization and cell cycle analysis  
 
Cells were pre-treated with 500nM MLN4924 for 15 hrs or arrested in G1/S phase 
prior to ultraviolet irration at the indicated intensity. For synchronization, cells 
were treated with 2.5 mM thymidine (Sigma) for 18 h, released from the G1/S 
block into fresh supplemented DMEM for 8 h and then treated again with 2.5 mM 
thymidine for 18 h. After release from the second block, cells were exposed to 
UV damage. Fluorescence Activated Cell Sorting (FACS) was used to analyse 
the cell-cycle distribution at the indicated times after UV release. Cells were 
harvested in PBS, fixed in 70% ethanol and pelleted before resuspended in 1ml 
PBS containing RNAse A (10µg/ml, Invitrogen) propidium iodide (20µg/ml, 
Sigma, P4170) for 30min. incubation at room temperature. Samples were 
analysed using a Becton Dickinson FACScan operated by the CELLQuest 
software. 
 
Immunofluorescence microscopy 
 
Cells were seeded on round coverslips 24hrs before treatment. After the 
HS/MG132 treatment, cells were washed twice with warm PBS and fixed with 4% 
formaldehyde for 10min. Cells were washed three times (5min) with warm PBS, 
and permeabilized with 1% Triton X-100 in PBS for 10min. Cells were washed 
3×10min with PBS before blocking with 0.05% Tween-20 + 1% Goat serum (from 
where) in PBS for 1hr. After blockage, cells were incubated with the appropriate 
primary antibody diluted in 0.05% tween-20 + 1% Goat serum in PBS for 1hr at 
room temperature (or overnight at 4oC). After 3×10min washes with 0.05% 
Tween-20 in PBS, cells were incubated with corresponding secondary antibodies 
diluted in 0.05% Tween-20 + 1% Goat serum in PBS for 1hr at room temperature 
in the dark. Samples were washed 3×10min with 0.05% tween-20 in PBS, and 
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then stained with DAPI (1/20000) for 20s at room temperature in the dark. Slides 
were washed 3x with PBS, mounted with Vectashield Mounting Medium (H-1000, 
Vector), sealed, and viewed under the microscope Leica DM6000 or Leica SP5-
SMD using metamorph software. The images were analyzed by ImageJ64 
software.  
 
Ni-NTA pull-down  
 
After the indicated treatment, cells were washed twice with ice cold PBS and 
scrabed in 1ml PBS. 200μl of each sample were pelleted at 14000rpm for 1min 
and lysed with 2xSDS. The 800μl left were lysed in 6ml 6M GmCl lysis buffer [6 
M Guanidinium-HCl, 10mM Tris-HCl (pH 8), 0.1M Na2HPO4/NaH2PO4, pH 8] 
supplemented with 10mM Imidazole and 10mM β-mercaptoethanol. 60μl of Ni-
NTA-agarose beads were added to the lysates and incubated overnight at 4ºC. 
Beads were pelleted by centrifuging at 2000rpm-5min at 4 C then were washed 
once with 750 μl of 6M GmCl lysis buffer, twice with 8M Urea pH 8 [8M Urea, 100 
mM Na2HPO4/NaH2PO4 (pH 8), 10 mM Tris-HCl (pH 8)] and three times with 
8M Urea pH 6.3 [8M Urea, 100 mM Na2HPO4/NaH2PO4 (pH 6.3), 10 mM Tris-
HCl (pH 6.8)], all wash buffers were supplemented with 0.1% Triton X-100 and 
10mM β-mercaptoethanol. For each wash, beads were spun at 5000rpm-1min. 
After the last wash, 100μl of elution buffer (2xSDS with 250mM Imidazole) was 
added, samples were heated at 95ºC for 2min, incubated for 20min at room 
temperature and spun at 14000rpm for 10min. Supernatants were collected and 
analyzed by western blot. 
 
Ni-NTA pull-down from pellet fraction 
 
Cells stably expressing 6His-NEDD8 were subjected to a subcellular fractionation 
after the appropriate treatment as previously described. Pellet fractions were 
washed 3 times with the buffer B and then resuspended in 1ml of 8M Urea, 100 
mM Na2HPO4/NaH2PO4 (pH 8), 10 mM Tris-HCl (pH 8) and sonicated 4×30s at 
30% amplitude (Branson Digital Sonifier). Insoluble particles were eliminated by 
centrifugation at 14000rpm-10min at 4oC. 100µl of each collected supernatant 
were mixed with equal volume of 2xSDS loading buffer. The rest was diluted up 
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to 6ml in the 8M Urea pH 8 buffer with 10mM Imidazole and 10mM β-
mercaptoehanol. The purification was then performed using 60µl of Ni-NTA 
agarose beads as previously described. 
 
Ni-NTA pull-down for mass spectrometry analysis 
 
After the indicated treatment, cells strably expressing 6His-NEDD8 or 6His-
NEDD8R74K were washed twice with ice cold PBS and scrabed directly in 6M 
GmCl lysis buffer. DNA was disrupted by sonication 10x30s at 41% amplitude 
(Branson Digital Sonifier). Insoluble particles were removed by centrifugation at 
15000rcf for 1h at 15ºC. Protein extract was filtered with 0.2-μm sterile filters and 
protein concentration was determined by BCA assay. Pre-washed Ni-NTA 
agarose beads were added to the lysate previously supplemented with 20mM 
Imidazole and 10mM β-mercaptoethanol for incubation at 4ºC for 16hrs. Beads 
were washed once with 1 ml of 6M GmCl lysis buffer, twice with 8M Urea pH 8, 
three times with 8M Urea pH 6.3 and three times with 8M Urea pH 8. All buffers 
were supplemented with 20mM Imidazole and 10mM β-mercaptoethanol. 
Proteins were eluted in three sequencial steps in elution buffer pH 8 [8M Urea, 
100 mM Na2HPO4/NaH2PO4 (pH 8), 10 mM Tris-HCl (pH 8), 250mM Imidazole 
and 10mM β-mercaptoethanol]. For each elutions the beads were pre-incubated 
10min in elution buffer. Proteins from lysate were submitted to 3 successive 
purifications/elutions process by adding new pre-washed beads. The protein 
concentration was determined by BCA assay. A fraction of the elutions were 
analyzed by western blotting. Selected elutions were subjected to in-solution 
digestion with the indicated endoproteinases. Peptides were desalted prior to 
mass spectrometry analysis.  
 
In-solution digestion and desalting of the peptides  
 
Proteins in 8M urea were supplemented with ammonium bicarbonate to 50mM. 
Reduction and alkylation were performed with 5mM DTT (45 min, RT) and 55mM 
iodoacetamide (20 min, RT in the dark), respectively. Samples were then diluted 
to 6M Urea concentration using 50mM ammonium bicarbonate. 1:50 (wt/wt) ratio 
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of Lys-C was added to the samples for digestion overnight at 25ºC. Subsequently, 
resulted samples were diluted to 2M Urea concentration with 50mM ammonium 
bicarbonate. Digestion with trypsin (1:50) was performed overnight, at 25ºC, still 
and in the dark. In-solution digested peptides were desalted using OMIX C18 
reversed chromatography StageTips (Agilent) following manufacture’s 
instructions. StageTips were kept at 4ºC before eluted for mass spectrometry 
analysis.  
 
SILAC-mass spectrometry analysis 
 
Cells were labeled in SILAC DMEM either with light (Lys0/Arg0) or heavy 
(Lys8/Arg10) amino acids supplemented with dialyzed FBS and standard 
antibiotics. In the experiments for 6His-NEDD8 conjugates analysis, cells grown 
in light medium were left at 37ºC whereas cells in heavy medium were heat-
shocked at 43ºC for 1h or pre-NEDP1 knockdowned by CRISPR/Cas9 approach. 
Respective lysates were mixed 1:1 prior to Ni-NTA purification appropriate for MS 
analysis as previously described.    
 
For pellet fraction analysis, cells grown in light medium were left at 37oC whereas 
cells in heavy medium were heat-shocked at 43oC for 2hrs. In the experiment of 
NEDD8 knockdown and MLN4924 treatment, control (light) and siNEDD8 
transfected cells (heavy) or control siRNA transfected (light) and MLN4924 
treated cells (heavy) were all heat-shocked at 43oC for 2hrs. For each condition, 
cells were collected in PBS, counted and mixed 1:1. Cell fractionation was 
followed and the pellet was resuspended in 2xSDS sample buffer. 50µg of protein 
were run for 15min on 4-12% precast NuPAGE and coomassie blue stained. 
Lanes were cut in 2 gel pieces and in gel trypsin digestion was performed as 
described in (Sun et al., 2006).  
 
Peptides were analyzed online by nano-flow HPLC-nanoelectrospray ionization 
using a Qexactive Plus mass spectrometer (Thermo Fisher Scientific) coupled to 
a nano- LC system (U3000-RSLC, Thermo Fisher Scientific). Desalting and 
preconcentration of samples were performed on-line on a Pepmap® precolumn 
(0.3 × 10 mm; Dionex). A gradient consisting of 0–40% B in A for 140 min (A: 
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0.1% formic acid, 2% acetonitrile in water, and B: 0.1% formic acid in acetonitrile) 
at 300 nl/min, was used to elute peptides from the capillary reverse-phase column 
(0.075 × 150 mm, Pepmap®, Dionex). Data were acquired using the Xcalibur 
software (version 4.0). A cycle of one full-scan mass spectrum (375–1,500 m/z) 
at a resolution of 70,000 (at 200 m/z), followed by 12 data-dependent MS/MS 
spectra (at a resolution of 17,500, isolation window 1.2 m/z) was repeated 
continuously throughout the nanoLC separation. Raw data analysis was 
performed using the MaxQuant software (version 1.5.5.1) with standard 
settings.  Used database consist of Humanentries from Uniprot (reference 
proteome UniProt 2017_03) and 250 contaminants (MaxQuant contaminant 
database). Relative proteins quantifications were calculated on the median 
SILAC ratios. 
 
Sample preparation and mass spectromety analysis (IMB, Germany)  
 
HCT116 NEDP1 depleted cells stably expressing 6His-NEDD8R74K were washed 
with PBS and lysed in modified RIPA buffer [50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1% NP-40, 0.1% Na-deoxycholate and supplemented with 
protease inihibitors] then incubated for 15 min on ice. Lysate was sonicated for 
3x30s at 30% amplitude (Branson Digital Sonifier) and cleared by centrifugation 
at 13,000rpm for 15 min. Supernantants were combine and measured for protein 
concentration using BCA assay. Around 200 mg of proteins were precipitated 
overnight in 4xVol cold acetone at -20ºC. Precipitated proteins were re-dissolved 
in denaturing buffer [6M Urea and 2M thiourea in 10mM HEPES at pH 8). 
Cysteines were reduced with 1 mM dithiothreitol for 45 min and alkylated with 5.5 
mM chloroacetamide for 30 min in the dark. Proteins were subsequently 
proteolysed in 1:100 and 1:500 with endoproteinase Lys-C (Wako Chemicals) 
overnight. Peptides were purified using reversed-phase Sep-Pak C18 cartridges 
(Waters), and dissolved in immunoprecipitation buffer [10 mM sodium phosphate 
and 50 mM sodium chloride in 50 mM MOPS at pH 7.2]. Di-glycine-modified 
peptides were immuno-enriched using PTMScan® Ubiquitin Branch Motif (K-ε-
GG) beads. Peptides were incubated for 4 h at 4°C on a rotation wheel. The 
beads were washed three times in ice-cold immunoprecipitation buffer followed 
by three washes in water. Immunoenriched peptides were eluted with 0.15% 
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trifluoroacetic acid in H2O, fractionated in three or six fractions using micro- 
column-based strong-cation exchange chromatography (SCX) and desalted on 
reversed phase C18 StageTips as described previously (Rappsilber, Mann, & 
Ishihama, 2007).  
 
Peptide fractions were analyzed on a quadrupole Orbitrap mass spectrometer (Q 
Exactive Plus, Thermo Scientific) equipped with a UHPLC system (EASY-nLC 
1000, Thermo Scientific). Peptide samples were loaded onto C18 reversed phase 
columns (15 cm length, 75 µm inner diameter, 1.9 µm bead size) and eluted with 
a linear gradient from 8 to 40% acetonitrile containing 0.1% formic acid in 2 hours. 
The mass spectrometer was operated in data dependent mode, automatically 
switching between MS and MS2 acquisition. Survey full scan MS spectra (m/z 
300 – 1700) were acquired in the Orbitrap. The 10 most intense ions were 
sequentially isolated and fragmented by higher-energy C-trap dissociation 
(HCD). An ion selection threshold of 5,000 was used. Peptides with unassigned 
charge states, as well as with charge states less than +2 were excluded from 
fragmentation. Fragment spectra were acquired in the Orbitrap mass analyzer. 
 
Raw data files were analyzed using MaxQuant (development version 1.5.2.8). 
Parent ion and MS2 spectra were searched against a database containing 88,473 
human protein sequences human protein sequences obtained from the 
UniProtKB released in December 2013 using Andromeda search engine. Spectra 
were searched with a mass tolerance of 6 ppm in MS mode, 20 ppm in HCD MS2 
mode, strict trypsin specificity and allowing up to 3 miscleavages. Cysteine 
carbamidomethylation was searched as a fixed modification, whereas protein N-
terminal acetylation, methionine oxidation modification of cysteines (mass 
difference to cysteine carbamidomethylation) and di-glycine-lysine were 
searched as variable modifications. Site localization probabilities were 
determined by MaxQuant using the PTM scoring algorithm. The dataset was 
filtered based on posterior error probability (PEP) to arrive at a false discovery 
rate of below 1% estimated using a target-decoy approach. Di-glycine lysine 
modified peptides with a minimum score of 40 and delta score of 6 are reported 
and used for the analyses. 
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Bioinformatic analysis 
 
For consensus sequence analysis, identified sites for NEDDylation with 
localization probability above 0.9 were analyzed. pLogo software (O’Shea et al., 
2013) was used to overlay sequence windows to generate a consensus 
sequence. IceLogo software (Colaert, Helsens, Martens, Vandekerckhove, & 
Gevaert, 2009) was used to generate Heatmaps in a similar manner as in pLogo 
sequence generation. All amino acids shown as enriched or depleted are 
significant with P<0.05. 
 
STRING network analysis was performed using the online STRING database 
(Szklarczyk et al., 2015), using NEDDylated proteins as input. Protein interaction 
enrichment was performed based on the amount of interactions in the networks, 
as compared with the randomly expected amount of interactions, with both 
variables directly derived from the STRING database output. Visualization of the 
interaction network was performed using Cytoscape version 3.4.0 (Shannon et 
al., 2003). 
 
For NEDDylation, SUMOylation and ubiquitination site comparative overlap 
analysis, all NEDDylation sites identified for NEDP1 KO cells in IMB were 
analyzed. All MS/MS-identified ubiquitination sites and SUMOylation sites were 
extracted from PhosphoSitePlus (www.phosphosite.org) (Hornbeck et al., 2012). 
For each data set, sites from mouse proteins were removed. Perseus software 
was used to generate a matrix where all proteins from all PTMs were cross-
referenced to each other. 
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CHAPTER I 
DECODING THE ATYPICAL AND 
CANONICAL NEDD8 PROTEOME 
 
BACKGROUND 
 
UBLs share structure and sequence similarity to ubiquitin. As with ubiquitin 
conjugation cascade, specific E1, E2, and E3 enzymes ensure the covalent link 
of each UBL to the lysine residue of substrates (Hochstrasser, 2009; van der 
Veen & Ploegh, 2012). Among all UBLs identified so far, NEDD8 is the most 
highly related to ubiquitin at the sequence and secondary structure levels with 60 
% identity and 80% homology, respectively (T. K. Kamitani et al., 1997). As well 
as between NEDD8 and ubiquitin itself, the E1 enzymes of NEDD8 (NAE) and 
ubiquitin (UBE1) share high extent of homology. Nevertheless, critical residues, 
along with structural, biophysical and thermodynamic properties, ensures the 
respective E1 enzymes discriminate between NEDD8 and ubiquitin for their 
specific modifications (Bohnsack & Haas, 2003; Burch & Haas, 1994; Kitahara et 
al., 2006; Souphron et al., 2008). Despite these features, it seems that the 
specificity between NEDDylation and ubiquitination pathways only occurs during 
cellular homeostasis. Recent studies have revealed that under cellular stress 
conditions, such as proteasome inhibition, heat shock or oxidative stress, global 
protein NEDDylation increase due to the activation by the ubiquitin enzyme UBE1 
rather by the NEDD8 enzyme NAE (Hjerpe, Thomas, & Kurz, 2012; Leidecker, 
Matic, Mahata, Pion, & Xirodimas, 2012). Interestingly, this response of NEDD8 
conjugation by the ubiquitin pathway leads to the formation of poly-NEDD8 chains 
and new incorporation of mixed NEDD8-ubiquitin chains into the "ubiquitin code" 
(Kim et al., 2011; Leidecker et al., 2012; Singh et al., 2012) (see Figure 1). The 
NEDD8 response to stress is reversible and cell recovery is accomplished once 
stress is alleviated (Leidecker et al., 2012). In principle, UBE1 has less affinity to 
activate NEDD8. Thus, part of the mechanisms that induce the "atypical 
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NEDDylation" by UBE1 is when the NEDD8: ubiquitin balance is affected either 
upon depletion of free ubiquitin or by the artificial increase in the levels of NEDD8 
through overexpression (Hjerpe, Thomas, Chen, et al., 2012; Leidecker et al., 
2012; Whitby et al., 1998). Remains an open question whether the NEDD8 
conjugation through the ubiquitination machinery and subsequent formation of 
hybrid NEDD8-ubiquitin chains has a physiological outcome. This crosstalk could 
represent either a stress signal that is detected by specific cellular factors, an 
alteration of the recognition of typical ubiquitin chains, or NEDD8 only replaces 
ubiquitin when free ubiquitin levels fall. (Abidi & Xirodimas, 2015; Lane, 2012; 
Singh et al., 2012; Singh, Sundar, & Fushman, 2014). Although under 
homeostasis the concentrations of free NEDD8 and ubiquitin are almost equal, is 
evident the increase of NEDDylation levels observed in many types of cancers, 
cancer-derived cell lines, and certain cell types. (Enchev et al., 2014; Hjerpe, 
Thomas, Chen, et al., 2012). Unquestionably, the study of the role of atypical 
NEDDylation and crosstalk between NEDD8 and ubiquitin pathways is critical to 
clarify what are the biological functions or repercussion within the cells.  
 
 
 
Figure 1. Modes of NEDD8 conjugation 
Activation of NEDD8 by NEDD8-activating enzyme (NAE) defines the canonical 
NEDDylation pathway under homeostatic conditions. Proteotoxic stress causes an 
increase in protein NEDDylation that depends on the activation of NEDD8 by the 
ubiquitin E1 enzyme UBE1. This leads to the formation of poly-NEDD8 and/or hybrid 
NEDD8–ubiquitin chains on target proteins (Abidi & Xirodimas, 2015).  
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The function of NEDD8 in homeostasis involves mainly the regulation of Cullin-
RING ligases (CRLs) through the modification of cullins. The family of cullin 
proteins is the best-characterized target for NEDD8. Cullins are scaffold proteins 
which under NEDDylation enhance the ubiquitination activity of the CRLs 
complex and, therefore, regulates the degradation of substrates by the ubiquitin-
proteasome system (UPS) (reviewed in Abidi & Xirodimas 2015). Besides cullins, 
recently additional relevant targets for NEDDylation have been identified such as 
p53, ribosomal proteins, and histones. These non-cullin substrates are involved 
in critical biological processes including cell cycle regulation, transcription, protein 
synthesis, DNA damage response, and apoptosis. (Abidi & Xirodimas, 2015; 
Rabut & Peter, 2008; M. Wang et al., 2011; Watson, Irwin, & Ohh, 2011; D. 
Xirodimas, 2008). Despite the obvious importance of NEDDylation, there is still a 
limited knowledge on its substrates. NEDDylation is a reversible process. Two 
main enzymes have shown great specificity for NEDD8 deconjugation: the multi-
component COP9 signalosome and the protease NEDP1 (also called DEN1 or 
SEPN8). The COP9 signalosome (CSN) complex is a zinc metalloprotease, 
which has low affinity for NEDD8 itself but more specifically promotes 
deNEDDylation of cullins (Birol et al., 2014; Enchev et al., 2012; Lingaraju et al., 
2014; Lyapina et al., 2001; C. Zhou et al., 2001). In contrast, NEDP1 is an 
NEDD8-specific protease that binds selectively to NEDD8, and not only can 
deconjugate NEDD8 from substrates but also catalyzes the processing of 
precursor NEDD8 to expose the C-terminal di-glycine motif necessary for its 
further activation (Gan-Erdene et al., 2003; Mendoza et al., 2003; Rabut & Peter, 
2008; Shen et al., 2005; Wu et al., 2003; D. Xirodimas, 2008). Compared with the 
CSN complex, NEDP1 is inefficient at deNEDDylating mono-NEDDylated cullins, 
however, is more effective in deNEDDylating poly-NEDDylated cullins (Wu et al., 
2003). Interestingly, the depletion of NEDP1 orthologs in S. pombe and D. 
melanogaster did not result in accumulation of NEDDylated cullins but the 
accumulation of new potential NEDDylated substrates. These studies suggested 
the great possible role of NEDP1 in the regulation of non-cullin substrates (Chan 
et al., 2008; Watson et al., 2011; L. Zhou & Watts, 2005). It is apparent that as 
for atypical NEDDylation, the role of the canonical NEDD8 pathway beyond 
cullins remains unclear. To elucidate the different biological outcomes of protein 
NEDDylation under homeostasis or stress status, in this work we developed 
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approaches that differentiate and determine the NEDD8 proteome from the 
canonical and atypical pathways through mass spectrometry analysis. 
 
RESULTS 
 
Mechanisms that differentiate between atypical and canonical NEDDylation 
 
NEDD8 protein conjugation can be trigger by two distinct pathways depending 
on the cellular status. It is well established that heat shock (HS), proteasome 
inhibition, and oxidative stress are some of the proteotoxic stimuli that induce 
global protein NEDDylation by the atypical Ube1 activation. In contrast, 
NEDDylation through the canonical NAE activation occurs under homeostatic 
conditions by mainly modifying cullins for the regulation of CRLs. The role of 
NEDD8 upon proteotoxicity remains unclear and, still little is known about the 
non-cullin substrates of NEDD8 through the canonical pathway. The large-scale 
identification of the NEDDylome is challenging due to the low intrinsic expression 
of NEDD8 in homeostasis and, due to the consequence of exogenous NEDD8 
overexpression to perturbed the NEDD8: ubiquitin balance. Therefore, special 
careful is needed in order to characterize and distinguish between both possible 
NEDDylation pathways. In this work, we determined different mechanisms to 
differenciate both ways of NEDD8 activation. Supported by the notion that the 
de-NEDDylating enzyme NEDP1 essentially regulates non-cullin substrates, 
here we established NEDP1 knockout (NEDP1 KO) cell lines using the recent 
CRISPR/Cas9 system (Ran et al., 2013). As expected, the depletion causes a 
dramatic increase on protein NEDDylation and, consequently, enables the 
identification of potential canonical NEDD8 substrates besides cullins. Therefore, 
while heat-shocked at 43ºC or treated cells with the proteasomal inhibitor MG132 
causes a progressive accumulation of atypical NEDDylated substrates, the 
NEDP1 depleted cells accumulates for canonical NEDD8 substrates (Figure 2A). 
In addition, to avoid NEDD8: ubiquitin unbalance in the cell, we generated stable 
cell lines expressing polyhistidine (6His)–tagged NEDD8 (6His-NEDD8) using a 
lentivirus based approach that provides low-level expression of the transgene 
similar to endogenous NEDD8 levels (Dull et al., 1998; Naldini et al., 1996). 
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Consequently, stable cell lines of the transgene guaranty reliable NEDDylation 
response. Then, specific 6His-NEDD8 conjugates can be highly enriched by 
nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography for further analysis 
(Figure 2B). 
 
A 
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Figure 2. Approaches to distinguish atypical and canonical NEDD8 proteome by 
MS analysis 
(A) Overview of the mechanisms that potentially discriminates between the atypical 
and canonical NEDD8 proteome. Either progressive heat-shock at 43ºC or treatment 
with MG132 (30 µM) in the indicated times causes proteotoxicity which triggers an 
increase of atypical NEDDylation through Ube1 activation. Instead, NEDP1 depleted 
clones (NEDP1 KO), resulted from a CRISPR/Cas9 strategy, causes an accumulation 
of canonical NEDD8 substrates through NAE activation. Western blot analysis showed 
for NEDD8 and NEDP1 antibodies respectively. (B) Left: schematic representation of 
a 6His-NEDD8 target purified by Ni-NTA pulldown from lentiviral infected cells. Right: 
Control or NEDP1 depleted HCT116 cells were either infected or not with lentivirus for 
stable expressing 6His-NEDD8 construct. NEDD8 conjugates were enriched using Ni-
NTA chromatography. Immunoblotting analysis from total cell lysates and Ni-NTA 
elution samples confirmed the low-level expression of 6His-NEDD8 and showed high-
specificity enrichment of their conjugates. 
 
 
Having established the mechanisms to differenciate between the two types of 
NEDDylation, furthermore, we applied the SILAC strategy in combination with 
mass spectrometry to study the dynamics of NEDD8 modification under the 
atypical and canonical pathway. HCT116 stable cell line expressing 6His-NEDD8 
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were metabolically labeled with “light” lysine/arginine (K0/R0) for control 
conditions and with “heavy” (K8/R10; + 18 Da shift) for heat shock (43°C, 1h) 
stress stimuli or for NEDP1 KO status, respectively. Subsequently, the respective 
“light” and “heavy” cell lysates were mixed in equal amount (1:1). 6His-NEDD8 
conjugated proteins were enriched by Ni-NTA affinity under denaturing conditions 
by three successive purification/elution processes (Figure 3A). Selected elution 
fractions with higher NEDDylation patterns were pulled together, either two 
samples from heat shocked cells (E1s of second and third bindings) and three 
samples from NEDP1 depleted cells (E1 of first binding with E2s of second and 
third bindings) respectively. (Figure 3B) Lys-C and trypsin endoproteinases were 
used for protein digestion followed by peptide purification using OMIX C18 
reversed chromatography for the final mass spectrometry analysis (LC-MS/MS) 
(Figure 3A). 
 
 
A 
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Figure 3. SILAC based quantitative proteomics to monitor atypical and 
canonical NEDDylation pathway 
(A) Overview of the workflow strategy used to characterize the NEDDylation dynamic 
upon the atypical and canonical pathway, respectively. (B) Western blot analysis from 
elution samples after consecutive Ni-NTA enrichments of the respective heat-shocked 
or NEDP1 depleted 6His-NEDD8 conjugates previously labeled and mixed. (*) Chosen 
elution fractions for MS analysis. 
 
NEDDylation of ubiquitin and SUMO as part of the proteotoxic stress 
response 
 
Following the SILAC quantitative analysis, we could characterize the atypical 
NEDD8 modification during HS-induced proteotoxicity. As expected, we identified 
ubiquitin as one of the proteins highest increased in NEDDylation upon heat 
shock but, interestingly, also SUMO1/2, Histone 2, NAE1 and ribosomal proteins 
exhibited high levels of enrichment in NEDD8 modification. This data confirmed 
the previously described NEDD8-ubiquitin mixed chains formation under 
proteotoxic stress (Leidecker et al., 2012) and suggest that the NEDDylation of 
the small ubiquitin-like modifier SUMO (formation of NEDD8-SUMO mixed 
chains) might be also a crucial part of the NEDD8 response. Furthermore, we 
found cullins as some of the proteins decreasing on NEDD8 modification, 
possibly indicating a compromised in their basal modification to release free 
NEDD8 for modifying different proteins during the stress. Another striking 
observation was the identification of NAE1 (regulatory subunit of the NAE 
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enzyme) as a substrate for NEDD8 during HS which might be crucial, together 
with the free NEDD8/ubiquitin ratio, for the unusual behavior of NEDD8 to use 
the ubiquitin pathway (Figure 4A). Previously in the laboratory, we observed that 
the accumulation of NEDDylated proteins upon HS proteotoxicity is characterized 
by a progressive translocation of the modified substrates from a cytosolic soluble 
fraction after mild HS (15 min) into an insoluble pellet fraction after prolonged HS 
(2hrs), leading to a possible aggregation of NEDDylated substrates after 
prolonged stress. By performing subcellular fractionation separating soluble 
(cytosol, nucleoplasm) from insoluble (pellet) fractions after mild and prolonged 
HS, we could detect a parallel increase response of protein NEDDylation, 
ubiquitination and SUMOylation into the insoluble fractions (Figure 4B). In 
addition, we confirmed the co-existence of NEDD8, ubiquitin and SUMO2 on the 
same substrates by using biochemical Ni-NTA isolation of the 6His-tagged 
NEDDylated substrates from the insoluble pellet fractions. As predicted, the 
isolated NEDDylated substrates were enriched with ubiquitin but also with 
SUMO2, thus confirming our SILAC data for NEDDylation upon heat shock stress 
response (Figure 4C). Interestingly, when cells were subjected to a severe 
proteotoxic stress, overnight MG132 treatment, nuclear co-localization of 
NEDD8/ubiquitin (Figure 4D) and NEDD8/SUMO2 (Figure 4E) was detected by 
immunofluorescence analysis which appeared as bright ring-like structures. 
Further analyses confirmed the formation of these nuclear ring-like NEDD8 
aggregates and their high co-localization with ubiquitin (Figure 4F). In conclusion, 
these observations suggest that the increase in NEDDylation upon proteotoxic 
stress causes the progressive accumulation of NEDD8 conjugates as nuclear 
aggregates together with ubiquitin and SUMO.  
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Figure 4. NEDD8, ubiquitin and SUMO2 co-exist on the same substrates upon 
proteotoxicity as nuclear ring-like aggregates 
(A) Scatter-plot of the SILAC 6His-NEDD8 purification under HS stress. Log2 ratios of 
heavy to light (H/L) mass-to-charge (m/z) peak correlated to the intensity of NEDDylated 
peptides under heat shock at 43ºC for 1 hour. Ubiquitin, SUMO1/2, histone and 
ribosomal proteins increased whereas cullin family members decreased on NEDDylation 
in response to the stress. (B) Stable U2OS cells expressing 6His-NEDD8 were either left 
at 37ºC (control) or heat-shocked at 43ºC for the indicated times. Cells were subjected 
to subcellular fractionation. Western blot analysis showed a progressive accumulation of 
NEDDylated, ubiquitinated and SUMOylated proteins in the insoluble pellet fraction after 
prolonged HS (120’). Tubulin was used as cytoplasmic marker and histone as nuclear 
marker. (C) Western blots of the Ni-NTA pull-downs of the whole cell extract (WCE) or 
insoluble pellet fractions of stable cells heat-shocked at 43ºC for 120’ indicating a high 
enrichment of ubiquitin and SUMO2 as part of the NEDDylated substrates. H1299 cells 
were pre-treated with MG132 (25μM-5h) or (5μM-ON), then fixed and stained for NEDD8 
(red) with either Ubiquitin (green) (D) or SUMO2 (green) (E). Nuclei were stained with 
DAPI (blue). Scale bars, 10μm. Pictures were acquired with a Leica DM6000 using 
metamorph software. (F) U2OS cells were either untreated or treated with MG132 (5µM-
ON) before staining for NEDD8 (red) and ubiquitin (green). Nuclei were stained with 
DAPI (blue). The co-localization between NEDD8 and ubiquitin in the ring-like structures 
was analyzed as described previously (Bailly et al., 2016; Bolte & Cordelieres, 2006). 
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Ribosomal proteins aggregate in response to proteotoxicity promoted by 
NEDD8  
 
As indicated above, prolonged periods of HS induce the formation of insoluble 
aggregates with a parallel aggregation and accumulation of NEDD8, ubiquitin and 
SUMO1/2. To further characterize the composition of protein aggregation 
induced by HS, we performed SILAC quantitative proteomics on the aggregates. 
H1299 cells were labelled with either light (K0R0) or heavy medium (K8R10) and 
either left at 37ºC (light) or heat-shocked (heavy) at 43ºC for 2hrs. Cells were 
mixed 1:1 ratio before subcellular fractionation and isolation of the insoluble pellet 
fraction, which was resuspended in 2xSDS buffer and sonicated. After in gel-
trypsin digestion peptides were identified and quantified by mass spectrometry 
as described in methods (Figure 5A). Approximately 1600 proteins significantly 
increased in the formation of aggregates upon prolonged HS stress in which, 
consistent with our previous data, ubiquitin, NEDD8 and SUMO1/2 showed highly 
accumulation (Figure 5B). Another distinguished observation was that among all 
the group of proteins which increased in the aggregates (above Log2 ratio 1), 
ribosomal proteins (RPs) were the most abundant with approximately 10% of the 
total number and 20% of the related overrepresented pathway (Figure 5C-D). 
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Figure 5. HS-induced aggregates are constituted mainly by NEDD8, ubiquitin, 
SUMO and ribosomal proteins 
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(A) Schematic overview of the SILAC quantitative proteomics strategy for investigate the 
protein composition of aggregates produced upon HS. (B) Scatter plot of the HS SILAC 
on aggregates indicate the Log2 ratios (H/L) correlated with the intensity of peptides. 
Protein aggregation increase upon prolonged HS (2h) with a notably parallel 
accumulation of NEDD8, ubiquitin, SUMO1/2, and ribosomal proteins. The red dots 
represent the ribosomal proteins. Same results obtained from a duplicate experiment. 
(C) Histogram representation of the HS SILAC on aggregates correlating the Log2 ratios 
(H/L) with the protein counts. ∼970 proteins were enriched with SILAC ratio above 1 on 
which approximately 10 % (∼90) corresponded to ribosomal proteins (colored in red). (D) 
STRING database analysis and bar graph representation of the KEGG pathways 
overrepresented on the proteins identified with H/L SILAC ratio >1. The top 10 highest-
enriched pathway descriptions are presented on the graph indicating the percentage 
corresponded to the total number of gene counts observed and their respective False 
Discovery Rate (FDR). The ribosome pathway (red bar) was the most significant 
overrepresented with 23% of the total observed gene count. 
 
 
The SILAC quantification on aggregates upon HS revealed their general protein 
composition which clearly showed the high accumulation of NEDD8, SUMO1/2, 
ubiquitin and RPs. We then addressed the potential role of NEDD8 in the protein 
aggregation induced by HS. Previous studies in the laboratory established that 
while short-term (36-48 hrs) knockdown of NEDD8 completely blocks the stress-
induced NEDD8 response, it does not have a crucial impact on cullin 
NEDDylation which is the major homeostatic target of NEDD8. In contrast, 
treatment with MLN4924, a specific inhibitor of the canonical NAE enzyme, has 
no effect on the stress-induced NEDDylation but almost fully blocks cullin 
NEDDylation (Figure 6A) (Leidecker et al., 2012). Based on that notion, we 
applied the above experimental settings to determine by SILAC quantitative 
proteomics the effect of NEDD8 itself on the composition of the HS-induced 
aggregates, and to distinguish between any potential related effects by cullin 
NEDDylation and CRL function. H1299 cells labelled with either light (R0K0) or 
heavy medium (R10K8) were divided in two sets. The first set of cells was 
transfected with control (light) or with NEDD8 (heavy) siRNAs. For the second 
set, control siRNA transfected cells were either treated with DMSO (light) or with 
MLN4924 (heavy). After 48hrs of transfection or MLN4924 treatment, cells were 
heat-shocked at 43oC for 2 hrs, collected in PBS, counted and then mixed 1:1 
ratio (control with siNEDD8) and (control-DMSO with MLN4924). This was 
followed by a subcellular fractionation and mass spectrometry analysis as above 
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(Figure 6B). The SILAC quantitative results identified proteins that increase or 
decrease in the aggregates during NEDD8 depletion but the most profound effect 
of NEDD8 knockdown was the general reduction of protein aggregation itself 
(∼40% decreased of total proteins). In particular, reduced aggregation was 
observed for a large number of ribosomal proteins (∼50 below Log2 ratio 0.5)  
(Figure 6C). Importantly, these effects were specific for NEDD8 knockdown and 
not observed upon inhibition of the canonical pathway and CRL function by 
MLN4924 (Figure 6D). Additionaly, by comparing the siNEDD8 with the MLN4924 
data, we obtained the proteins which aggregate less and more specifically by the 
NEDD8 depletion (Figure 6E). The absence of NEDD8 significantly reduced the 
aggregation of approximately 350 proteins (75%) in compare to the ∼115 proteins 
which aggregated more (25%). Interestingly, the protein composition of the less 
aggregated proteins was highly overrepresentated with the ribosome related 
pathway (Figure 6F). Thus, this data indicates that atypical NEDDylation induces 
the aggregation of a specific subset of proteins (mainly RPs) which consequently 
affects the composition of the HS-induced aggregates. 
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Figure 6. Role of NEDD8 in the HS-induced aggregation of ribosomal proteins 
(A) Mechanism used to discriminate between canonical and atypical NEDD8 response 
upon HS. H1299 cells were transfected with control or NEDD8 siRNA or treated with 
MLN4924 (200 nM) for 48 hrs before were heat-shocked or not as indicated. Cell extracts 
were used for western blotting for the indicated proteins. MLN4924 decreased only the 
canonical NEDDylation whereas siNEDD8 only affected the atypical NEDD8 response 
(B) Workflow overview of the SILAC proteomics strategy to determine the role of 
canonical and atypical NEDD8 pathway on protein composition of the HS induced 
aggregates.  Scatter plots indicating the Log2 ratios (H/L) of SILAC quantification effect 
during NEDD8 knockdown (C) and MLN4924 treatment (D). Ribosomal proteins were 
significantly affected by the depletion of atypical NEDDylation (siNEDD8). Same results 
were obtained from duplicate experiments. (E) Scatter plots comparing siNEDD8 with 
MLN4924 SILAC data. Proteins indicated in red and blue were either less or more 
aggregated upon HS during NEDD8 knockdown (inhibition of atypical NEDDylation) but 
not during MLN4924 treatment (inhibition of canonical NEDDylation). (F) Left: Pie chart 
of the number of proteins less aggregated (red) and more aggregated (blue) selected 
from the analysis in E. Right: Table indicating the highest KEGG pathways 
overrepresented in the less and more aggregated proteins respectively from STRING 
database analysis. 
 
 
Given that the atypical NEDDylation induce the aggregation of RPs, we assumed 
that NEDD8 is directly modifying the aggregated RPs upon proteotoxicicity. First, 
we reanalyzed the cellular extracts from Figure 4B and blotted against the 
ribosomal protein RPL7, which was identified in our proteomic analysis and 
previously reported to be NEDDylated (D. P. Xirodimas et al., 2008). As expected, 
the ribosomal protein accumulates in the insoluble pellet fraction after prolonged 
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HS, confirming similar response and co-localization with NEDD8, ubiquitin, and 
SUMO2 (Figure 7A). Secondly, to determine the NEDDylation of RPs in the 
aggregates, HCT116 cells stably expressing 6His-NEDD8 were heat-shocked or 
treated with MG132, then subjected to a subcellular fractionation. Pellet fractions 
were solubilized with 8M urea, and sonicated. 6His-tagged NEDDylated proteins 
were isolated by Ni-NTA pull down and blotted against the ribosomal protein 
RPL7. We could detect a polyNEDDylation of RPL7 upon proteotoxic stress, 
which validate a direct modification of NEDD8 triggered by the atypical 
NEDDylation pathway (Figure 7B). Finally, by immunofluorescense analysis we 
identified that after severe proteotoxic stress (MG132-ON), RPL7 accumulates 
within the nuclear ring-like structures stained with NEDD8 and ubiquitin (Figure 
7C-D). As well as for RPL7, the ribosomal protein RPL11 which was also identified 
in our data, presented the same results (data not shown). In conclusion, we 
confirmed the direct NEDDylation of some aggregated RPs upon proteotoxic 
stress which appeared sorrounded by the nuclear ring-like structures.   
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Figure 7. NEDDylation of aggregated ribosomal protein upon proteotoxic stress 
(A) Cellular extracts from the experiment in Figure 4B were immunoblotted against RPL7 
which accumulated in the pellet fraction after HS for 2 h. This analysis confirmed a co-
localization with NEDD8, ubiquitin and SUMO2. (B) Stably HCT116 cell line expressing 
6His-NEDD8 were heat-shocked at 43ºC (left) or treated with MG132 at 25 µM (right) for 
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Canonical NEDDylation controls NEDD8 enzymes and polyNEDD8 chain 
formation 
 
NEDD8 is mainly modifying the cullin family members during cellular 
homeostasis. However, it is possible that many other proteins are indeed 
NEDDylated through NAE activation, but their modification may exist transiently 
or in low levels during this physiological condition. The enzyme NEDP1 is one of 
the proteases showing greatest specificity for NEDD8 and, interestingly, previous 
results have demonstrated its high potential to regulate non-cullin substrates 
(Chan et al., 2008; D. P. Xirodimas et al., 2008). Therefore, here we developed 
NEDP1 KO cell lines which successfully increased the accumulation of new 
potential NEDDylated proteins (see Figure 2). To further study the dynamic 
modification of canonical NEDDylation regulated by NEDP1, we performed 
SILAC quantitative proteomics for the NEDP1 depleted cells stably expressing 
6His-NEDD8. Different elutions from the consecutive Ni-NTA purifications were 
selected and analyzed separetly by MS (see Figure 3). Two replicates with three 
elution samples each was analyzed (6 samples in total) from which we obtained 
similar results. As expected, our SILAC quantitative analysis detected NEDD8 
itself as one of the substrates highly NEDDylated when NEDP1 is deleted, 
confirming its crucial role to process polyNEDD8 chains. A comparable 
observation was previously obtained in the preference of NEDP1 to process 
hyper-NEDDylated rather than mono-NEDDylated CUL1 in vitro. (Wu et al., 
2003). Moreover, components of the NEDD8 conjugation pathway such as NAE1, 
UBA3 and UBE2M were significantly increased for NEDDylation upon NEDP1 
depletion (Figure 8A). Certainly, functional protein association analysis showed 
that among all the proteins identified with Log2 ratio above 1 were principally 
2 h, and then subjected to subcellular fractionation. NEDDylated substrates from pellet 
fractions were solubilized and enriched by Ni-NTA pull-down as described in methods. 
Western blot analysis validated the NEDDylation of RPL7 upon proteotoxicity. HCT116   
cells were transfected with RPL7-GFP and 48 hrs later were treated or not with MG132 
(5µM-ON). After fixation cells were stained for RPL7-GFP (green) with either NEDD8 (C) 
or ubiquitin (D) (red). Enlarged insets represent the NEDD8/ubiquitin ring-like structures 
surrounding the aggregated RPL7. Nuclei were stained with DAPI. Scale bars indicate 
10 µm. Pictures were acquired with Leica DM6000 using metamorph software. 
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enriched for the protein NEDDylation process itself (NEDD8 and the canonical 
enzymes) but also for other biological processes such as protein localization, 
protein transport and cellular metabolism (Figure 8B). In contrast, no biological 
process was significantly enriched among the proteins with less NEDDylation 
upon NEDP1 depletion. Nevertheless, we could observe in one of the elution 
samples analysis that CUL5 decreased for NEDDylation in the absence of 
NEDP1 with a Log2 ratio of -1 (Figure 8A). This observation suggests as it 
happened during stress conditions that the formation of polyNEDD8 chains can 
compromise the free NEDD8 availability for regulating cullins. Furthermore, we 
could validate the modification of the E1 regulatory subunit NAE1 (APPBP1) with 
NEDD8 coordinated by NEDP1 (Figure 8C). This modification was also reported 
during the depletion of NEDP1 ortholog in Arabidopsis thaliana (Mergner, 
Heinzlmeir, Kuster, & Schwechheimer, 2015) which confirms its NEDDylaion 
controlled by NEDP1 and provided evidence of the importance of its functional 
regulation by NEDD8. Interestingly, the E1 catalytical subunit UBA3 and the E2 
enzyme UBE2M appeared to have even more rates of NEDDylation moderated 
by NEDP1 than the regulatory subunit APPBP1 (see Figure 8A). Unquestionably, 
the function of NEDP1 in maintaining a particular NEDD8 pathway activity in the 
cells is still to be clarified and therefore would be an important area for further 
research. In conclusion, our data proposed that the cullin-independat canonical 
NEDDylation controlled by NEDP1 is mainly involved in the protein NEDDylation 
process itself. Clearly, SILAC quantitative analysis is a powerful tool to determine 
the dynamic of a specific process. However, it cannot provide a broader global 
identification of proteins. Consequently, to elucidate the identity and function of 
additional NEDD8 conjugates, the next section of this work is focused on the 
large-scale identification of NEDD8 targets either regulated by the atypical 
activation but especially from the canonical pathway. 
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Figure 8. NEDD8 controls its canonical protein NEDDylation by NEDP1 regulation 
(A) Scatter-plot of the SILAC 6His-NEDD8 purification under NEDP1 depletion. Log2 
ratios of heavy to light (H/L) mass-to-charge (m/z) peak correlated to the intensity of 
NEDDylated peptides. NEDD8 itself, as well as NEDD8 enzymes such as NAE1, UBA3, 
and UBE2M were highly increased in the absence of NEDP1. (B) Table representation 
indicating the highest biological processes (GO) overrepresented in the more 
NEDDylated proteins in NEDP1 KO cells (ratio >1) from STRING database analysis. (C) 
HCT116 lysates from control or NEDP1 depleted cells either stably expressing 6His-
NEDD8 or not were subjected to Ni-NTA purification in denaturing conditions and 
immunoblotted against APPBP1 (NAE1). Covalent conjugation of APPBP1 by NEDD8 
is observed only in 6His-NEDD8 conjugates from NEDP1 KO cells. 
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IDENTIFICATION OF NEDD8 SUBSTRATES 
AND MODIFICATION SITES 
 
BACKGROUND 
 
Post-translational modifications (PTMs) are crucial for various signaling pathways 
as well for the maintenance of cellular protein homeostasis. The large-scale 
determination of PTMs have generated valuable data into many biological 
functions, but most of their analysis have encountered many obstacles over an 
extended period due to a lack of suitable methods (Mann & Jensen, 2003). In 
fact, several PTMs, such as ubiquitination, were discovered by chance during 
studies on single proteins or cellular processes by using standard molecular and 
biochemical techniques (Hershko, 1996; Mann & Jensen, 2003). Nowadays, the 
use of quantitative mass spectrometry (MS) to investigate cell proteome PTMs 
has provided successful results, not only in the broad identification of modified 
proteins but also in the dynamic mapping of their modification sites. Nevertheless, 
large-scale identification of post-translational modification sites still faces 
analytical challenges due to the inability of current mass spectrometers to detect 
all peptide sequences generated by proteome digestion. Besides, PTMs are 
primarily exhibited at substoichiometric levels which considerably impede their 
analysis and identification (Choudhary & Mann, 2010; Parker et al., 2010; 
Sylvestersen et al., 2013; Zee & Garcia, 2012). Protein ubiquitination is the 
covalent attachment of ubiquitin by its C-terminus linked to an ε-amino group of 
the Lys residue of a substrate. This linkage is an important PTM involved in 
numerous cellular processes, including the well-studied regulation of protein 
degradation through the ubiquitin-proteasome system (UPS) (Hershko & 
Ciechanover, 1998). However, the analysis of global ubiquitination has been 
particularly challenging because of its inherent large mass (∼8 kDa) and its rapid 
modification turnover (Peng et al., 2003). Therefore, over the last decade, many 
CHAPTER II 
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technical advances have been developed to improve the enrichment and final 
detection of ubiquitinated proteins and modification sites by mass spectrometry-
based proteomics (reviewed in Heidelberger et al., 2016; Sylvestersen et al., 
2013). The shotgun (or bottom-up) proteomics approach commonly involves 
trypsin enzymatic digestion which cleaves after lysine and arginine residues. 
Given that the C-terminal sequence of ubiquitin is Leu73-Arg74-Gly75-Gly76, the 
tryptic peptide of a ubiquitinated protein releases two useful features. First, the 
Gly-Gly (diglycine) remnant signature attached to the modified lysine which is no 
longer recognized by trypsin. The second is the extra ∼114Da mass shift on the 
modified peptide corresponding to the diglycine motif on the lysine which is 
further used as search criteria for MS detection of precise sites of ubiquitination 
(Kirkpatrick, Denison, & Gygi, 2005; Komander, 2009; Peng et al., 2003). Both 
the improvement in high-resolution mass spectrometry and the generation of Lys-
ε-GlyGly (K-ε-GG) antibodies, which specifically recognize and enrich diglycine 
modified peptides, allowed the first proteome-wide detection of more than 10,000 
endogenous ubiquitination sites in human cells (Kim et al., 2011; S. a. Wagner et 
al., 2011; Xu, Paige, & Jaffrey, 2010). However, the modification by the ubiquitin-
like proteins NEDD8 and ISG15 also results in a K-ε-GG motif after trypsin 
digestion. Therefore, one limitation of the trypsin remnant profile is its incapacity 
to distinguish between ubiquitinated, NEDDylated and ISG15ylated sites (Udeshi 
et al., 2013). Despite the lower expression levels of NEDD8 in the cell, it has been 
shown that up to 6% of identified di-Gly remnants could be derived from 
NEDDylation under homeostasis (Kim et al., 2011). Cullins represent the main 
NEDD8 substrates by its ligation to a conserved Lys in their C-terminal’s winged 
helix-binding (WHB) domain (Duda et al., 2008; Pan et al., 2004). Consequently, 
NEDDylation is considered to only modify and regulate Cullin-RING ligases 
(CRLs) (Lydeard et al., 2013). Indeed, recent structural studies have revealed the 
specific mechanism that ensures the preferential modification of cullin with 
NEDD8 by the multifunctional RING E3, RBX1 (Scott et al., 2014). However, 
novel additional targets and modification sites for NEDD8 have been identified 
which include physiologically important proteins such as transcription factors, 
signaling receptors, components of the protein synthesis and apoptotic regulators 
(Abidi & Xirodimas, 2015; Rabut & Peter, 2008; M. Wang et al., 2011; Watson et 
al., 2011; D. Xirodimas, 2008). These findings suggest that a more diverse 
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spectrum of biological processes is controlled by NEDDylation. The reported 
NEDDylation sites in non-cullin substrates have been identified by both mass 
spectrometry and mutagenesis methods. Nevertheless, the majority of these 
novel reported NEDD8 targets are also substrates for ubiquitination and, their 
NEDDylation is trigger by ubiquitin E3-ligases. Hence, the current thinking is that 
only the members of the cullin family are the genuine physiological NEDDylation 
targets (Enchev et al., 2014). Abnormal upregulation of global NEDDylation is 
found in several types of cancer (Chairatvit & Ngamkitidechakul, 2007; Lee & 
Zhou, 2010; H. Li et al., 2014; L. Li et al., 2014; T. Li, Guan, Huang, Hu, & Zheng, 
2014; Salon et al., 2007; X. Wang et al., 2014). This pattern gives evidence of 
the importance of NEDD8 modification in the normal physiology of cells. In effect, 
the significance of protein NEDDylation has been supported by the success of 
the MLN4924 inhibitor in the treatment of certain types of cancer which is 
currently in Phase II clinical trials (Nawrocki, Griffin, Kelly, & Carew, 2012). 
MLN4924’s action in blocking protein NEDDylation downstream of NAE for 
potential anti-tumor effects has been focused on the resulted CRL inhibition and 
accumulation of CRL targets (T A Soucy et al., 2009; Teresa A Soucy, Dick, 
Smith, Milhollen, & Brownell, 2010; Swords et al., 2010). Considering that many 
of the reported non-cullin NEDD8 targets include not only cell cycle, 
transcriptional and apoptotic regulators but also tumor suppressors and DNA 
damage response mediators, supports the notion that also non-cullin NEDD8 
conjugation might have key roles in the therapeutic efficacy of MLN4924 in the 
clinic (Abidi & Xirodimas, 2015; Enchev et al., 2014; Watson et al., 2011). 
Although protein NEDDylation is emerging as an important regulator of several 
cancer-associated pathways, there is still a limited knowledge of the non-cullin 
substrates controlled by NEDD8. The current experimental MS approaches 
cannot determine large and authentic specific targets and modification sites for 
NEDD8 due to its basal conjugation levels in homeostatic conditions, but as well 
for its high similarity and cross-talk with ubiquitin. In this work, we aimed to 
determine criteria strategies to distinguish between NEDD8 and ubiquitin 
conjugation to define NEDD8 proteome besides cullins with a wide specific profile 
of modifications sites for NEDDylation.  
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RESULTS 
 
Developing a point mutant NEDD8 strategy to distinguish between NEDD8 
and ubiquitin substrates and modification sites by MS analysis 
 
The current proteomic studies cannot distinguish between NEDD8, ISG15, and 
ubiquitin modification, as those molecules provide the same signature on the 
modified lysine after trypsin digestion. In the same manner of as the analysis of 
ubiquitination sites, the use of immunoaffinity purification with a diGly-Lys-specific 
antibody has been adapted for the broad identification of SUMOylation sites, the 
conjugation by the small ubiquitin-like modifier SUMO (Tammsalu et al., 2014). 
Here, we developed a method based on this mutation strategy to guarantee a 
site-specific assessment of NEDDylation. Our approach consists of a tagged 
point mutant of NEDD8 with Arg74 mutated to Lys. Thereby, digestion with Lys-
C provides a unique diglycine signature on modified lysines which specifically 
identify NEDDylation sites on substrates (Figure 9A). The method involves the 
establishment of stable cell lines expressing polyhistidine (6His) – tagged NEDD8 
mutant (6His-NEDD8R74K) by a lentivirus infection approach. 6His-NEDD8R74K 
conjugated proteins can be purified under denaturing conditions by Ni-NTA 
chromatography and subsequently cleaved with the endoproteinase Lys-C. A di-
Gly Lys-specific antibody is then used to enrich NEDD8R74K remnant-containing 
peptides for mass spectrometry analysis (LC-MS/MS) (Figure 9B). Previously in 
the laboratory, we generated similar systems with NEDD8 wild type using the 
lentivirus-based approach which provides low-level expression of the transgene 
similar to endogenous NEDD8 levels (see Figure 2B) . Importantly, we have 
tested and confirmed that the NEDD8R74K construct also expresses as 
endogenous NEDD8 in homeostatic conditions. NEDD8R74K is negatively 
affected to modify cullins by the treatment with the inhibitor MLN4924 and 
instead, not altered by the knockdown of the ubiquitin-activating enzyme UBE1, 
indicating that the activation of NEDD8 mutant during homeostasis is UBE1 
independent but NAE specific. Moreover, we examined the accumulation of 6His-
NEDD8R74K conjugates upon proteotoxic stress and NEDP1 depletion. By 
comparing with the endogenous NEDD8 and 6His- NEDD8WT we could observe 
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the vast ability of the mutant to increase the NEDDylation levels in the NEDP1 
KO cells. Nevertheless, the response of NEDD8R74K to proteasome inhibition 
and, most notably, heat shock was not as abundant as the dramatic NEDP1 
dependent accumulation (Figure 9C). This observation indicates that the 
NEDD8R74K mutant is less efficient to modify substrates by the atypical UBE1 
dependent pathway. Even in general the increase of NEDDylation is less 
dramatic during proteotoxic stress than during NEDP1 depletion (see Figure 2A), 
another explanation could be that the mutation of NEDD8 in the residue 74 might 
affect the recognition and further activation by the UBE1 enzyme. Likewise, the 
residue 72 on NEDD8 and ubiquitin seems to be crucial for the discrimination and 
specific activation of the distinct E1 enzymes (Walden et al., 2003). In conclusion, 
our NEDD8 mutation strategy enables the specific identification of NEDDylation 
sites by differentiating between the ISG15 and ubiquitin modification sites based 
on the diglycine remnant released under Lys-C digestion.  
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Figure 9. NEDD8 point mutation strategy to identify specific substrates and 
modification sites by MS analysis 
(A) Sequence alignment of matured human ubiquitin, ISG15, and NEDD8 which 
terminate in a diglycine motif. In contrast to the endogenous protein, a point mutation of 
NEDD8 in Arg74 to Lys provides a unique GG signature on modified lysine residues 
upon digestion with Lys-C. The sequence of the predicted peptide after Lys-C digestion 
is underlined and highlighted in bold. Lys-C cleavable C-terminal lysine residue is 
colored in red. (B) Lentivirus infection provides stable protein expression of 6His-
NEDD8R74K mutant construct in cells. The biochemical purification of 6His-NEDD8R74K 
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The capacity of the mutantion approach to obtain specific NEDD8 
substrates and modification sites 
 
To obtain a NEDDylation site spectrum from the atypical and canonical pathway 
we analyzed NEDD8R74K substrates and sites from different conditions. For the 
atypical NEDDylation (UBE1 dependant), we treated a 6His-NEDD8R74K stable 
cell line with MG132 (25μM, 5 hours) to cause proteasome inhibition. In contrast, 
for the study of canonical NEDDylation (NAE dependant), we analyzed a NEDP1 
KO stable cell line developed previously in the laboratory by the CRISPR/Cas9 
approach (see Figure 2). Cells were lysed using denaturing conditions and 6His-
NEDD8R74K conjugates were purified through Ni-NTA columns. Proteins from 
respective lysates were subjected to three successive purification/elution 
processes, to recover a maximum of NEDDylated proteins (set of three elutions 
per Ni-NTA binding) (Figure 10A). For further analysis by Cell Signaling 
Technology service (CST, United States), we selected and combined three 
samples for the MG132 elutions (E1 from each binding) and six samples from the 
NEDP1 KO elutions (E1 and E2 from each binding). The CST facility performed 
the following 3 steps: (i) LysC and additional GluC digestion to help truncate long 
substrate peptides, (ii) the Lys-ε-GlyGly immunoprecipitation to enrich peptides 
containing diGly-Lys, (iii) the final LC-MS/MS analysis by using specific 
parameters for the identification of low-abundance peptides from post-
translational modifications (PTMScan). (Figure 10B). By using this novel strategy, 
we were able to identify specific targets and modification sites for NEDD8. 
Clearly, we acquired more NEDD8 substrates and modification sites under 
NEDP1 KO condition (342 proteins / 491 sites) than after MG132 treatment (138 
conjugates allows to distinguish and identify specific NEDD8 covalently modified lysines 
on substrates by MS analysis. (C) Comparison of the NEDDylation response under 
various conditions in whether parental non-lentivirus infected HCT116 cells, stable 
expressing 6His-NEDD8WT or 6His-NEDD8R74K. The lysates were either unstressed  
(Control, 37ºC), UBE1 knock downed (siRNA), MLN4924 treated (16hrs at 1µM), heat-
shocked (1h at 43ºC), MG132 treated (25µM, 5hrs) or NEDP1 depleted (CRISPR-Cas9 
approach). Ni-NTA purifications of the respective cell lines were immunoblotted against 
NEDD8. 
 76 
proteins / 240 sites), probably due to the lower rate response of the mutant by 
the atypical NEDDylation as observed in the immunoblotting analysis. 53 proteins 
were identified in both conditions which indicate that general NEDDylation 
independently of the pathway (atypical or canonical) might regulate common 
proteins (Figure 10C). Interestingly, not all of them shared the same modification 
sites (Figure 10D-E) but more accurate comparative analyses are needed in order 
to address these differences observed in NEDD8 site modifications within 
proteins. Furthermore, to characterize the cellular processes in which the proteins 
of our NEDD8R74K data set are involved, derived from both MG132 treated and 
NEDP1 depleted cells, we performed a gene ontology (GO) enrichment analysis.  
The analysis showed functional annotations of proteins statistically 
overrepresented in biological processes including protein NEDDylation itself, 
chromatin organization, gene expression regulation, cellular biogenesis, RNA 
processing and DNA damage response (Figure 10F). This observation suggests 
that the majority of the identified proteins fulfill their function in the nuclear cellular 
compartment which correlates with the statement that overall NEDD8-conjugated 
proteins appeared to reside predominantly in the nucleus (T. K. Kamitani et al., 
1997). Importantly, these findings are coherent with our previous quantitative 
results on the proteins regulated by the atypical and canonical NEDDylation. 
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Figure 10. NEDD8 mutation approach enables broad identification of substrates 
and modification sites 
(A) Overview of MS-based proteomics workflow for NEDD8 substrates and sites 
identification. Stable cells expressing 6His-NEDD8R74K after proteasome inhibition with 
MG132 (atypical pathway) or NEDP1 depletion (canonical pathway) were lysed using 
denaturing conditions for further Ni-NTA biochemical purification, Lys-C and GluC 
digestion, diGly-Lys peptide enrichment and final MS analysis. (B) Western blots show 
the consecutive Ni-NTA elution samples from respective 6His-NEDD8R74K lysates after 
three successive purification/elution processes. (*) Chosen elution fractions for MS 
analysis. (C) PTMScan analysis identified around 240 sites in 138 proteins for atypical 
NEDDylation after MG132 treatment and 491 sites in 342 proteins for canonical 
NEDDylation under NEDP1 knockdown on which 53 proteins were common for both 
conditions. (D) LC-MS/MS results identified around 289 proteins / 377 sites specific for 
NEDP1 KO cells and 85 proteins / 120 sites specific for MG132 treated cells, 
respectively. 53 proteins were found in both conditions but, the total 173 sites designated 
among these proteins were 53 sites specific for NEDP1 KO, 59 sites for MG132 and 61 
sites were common for both conditions. (E) Table shows examples of prevalent proteins 
found in both conditions with differences in their modifications sites by NEDD8. PCNA, 
Proliferating cell nuclear antigen. H2B, Histone H2B type. COPS7A, COP9 signalosome 
complex subunit 7a. ENO1, Alpha-enolase. FABP5, Fatty acid-binding protein. XRCC5 
(also Ku80), X-ray repair cross-complementing protein 5. DCUN1D1, DCN1-like protein 
1. PTMA, Prothymosin alpha.  (F) NEDD8 modifies highly interconnected functional 
networks of proteins. STRING database analysis and Cytoscape visualization shows that 
putative NEDD8 substrates are significantly overrepresented in Gene Ontology (GO) 
biological processes including chromatin organization, RNA processing and DNA 
damage response and repair. 41.82 and 4.80e-06 for protein NEDDylation, 6.38 and 
5.55e-23 for chromatin organization, 3.04 and 9.05e-05 for RNA processing, 4.12 and 
1.46e-05 for DNA damage response/repair are the respective fold enrichment and p-
values associated with GO parameters in each biological process term. 
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Improved workflow led to an increase of NEDD8 site identification 
 
Given the success of the NEDD8R74K strategy, we developed a workflow 
optimization to further increase the number of identified sites. This work was 
performed in collaboration with Dr. Petra Beli´s laboratory from the Institute of 
Molecular Biology (IMB) in Mainz, Germany. The previous protocol was adapted 
by first analyzing the NEDP1 KO depleted cells which show a dramatic increase 
of protein NEDDylation related to the canonical pathway. We changed the 
preparation of lysates from denaturing conditions to native conditions for 
subsequent acetone precipitation. Instead of performing Ni-NTA biochemical 
purification of 6His-NEDD8R74K substrates, proteome from lysates was directly 
digested with Lys-C, and the resulted peptides were submitted to K-ε-GG 
immunoprecipitation for di-glycine enrichment to the final LC-MS/MS analysis 
using specific parameters for PTMs mapping (Figure 11A). This first workflow 
approach (Experiment 1), gave us a total identification of ∼130 NEDD8 position 
sites within ∼100 proteins. Secondly, we performed another approach 
(Experiment 2) to enhance the identification by decreasing the complexity of Lys-
C digested peptides by fractionating them with strong cation-exchange 
chromatography (SCX) using three different consecutive elution buffers (pH 4, 7 
and 11 respectively). Fortunately, this second approach increased the number of 
identified sites for NEDD8R74K-modified proteins (∼270 sites within ∼180 proteins) 
by almost two-fold. In a third approach (Experiment 3), we used double the 
amount of starting proteome material for Lys-C digestion and splitted in two 
separate diGly enrichments. The resulted diglycine containing peptides were 
combined and then fractionated into six different SCX fractions (elution buffers 
with pH 4, 5, 6, 7, 8.5 and 11 respectively). Indeed, the final LC-MS/MS analysis 
from this experiment showed us that we could enrich by nearly more than 5 times 
the NEDD8 identification profile from ∼130 at the beginning to ∼740 sites within 
∼410 proteins. Finally, we repeated the 3rd optimized approach (Experiment 4) 
not only to estimate the reproducibility of the based enrichment workflow but also 
to extend the number of total unique NEDD8 identification sites. The duplicate 
could identify around 520 sites in ∼300 conjugated proteins of which 243 sites 
(24%) and 209 proteins (40%) were common between replicates but, importantly, 
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around 280 sites were specific to this new result. The comparison of the 
duplicates indicates that the degree of reproducibility can fluctuate from 
deviations in the manipulation of samples to reactants and mass spectrometer 
efficacy. In general, by matching all the analyses together from the consecutive 
optimizations, we successfully improve the strategy by identifying for the first time 
an extensive total of ∼1,100 NEDDylated sites in ∼530 proteins (Figure 11B). 
From this, we identified a total of ∼4,500 protein groups of which ∼530 (11%) 
contained the ∼1,100 unique Lys-diGly motifs for NEDDylation. To ensure 
accurate data, we observed that 87% of our identifications (around 908 sites in 
494 proteins) had a localization probability above 0.75. In conclusion, this study 
confirms that the double parallel antibody-based enrichment in combination with 
NEDD8R74K-modified peptide fractionation increase the identification of 
NEDDylated sites in substitution of the nickel affinity purification step performed 
previously. 
 
A 
 
 82 
B
 
 
 
Figure 11. Workflow optimization of NEDD8R74K strategy identified over 1,000 sites 
upon NEDP1 depletion 
(A) Schematic overview of the NEDD8R74K workflow optimizations and their individual 
MS results. For the first approach (Exp. 1), lysates from stable HCT116 cell line 
expressing 6His-NEDD8R74K were prepared in native conditions instead of denaturing 
conditions. 6His-NEDD8R74K conjugates were not purified by nickel affinity 
chromatography but, in contrast, the whole proteome from lysates was precipitated with 
acetone. The subsequent procedures consisted in the digestion with Lys-C 
endopeptidase and the diGly-based immunoprecipitation enrichment of NEDDylated 
peptides for the final high-resolution LC-MS/MS analysis. In the second approach (Exp. 
2) the resulted enriched peptides from K-ε-GG immunoprecipitation (IP) were separated 
in three different pH-based fractions from strong cation- exchange (SCX) 
chromatography. For the third approach (Exp. 3), the Lys-C peptides were divided and 
subjected into two parallel IP for K-GG motif enrichment and further distribution into six 
eluted fractions from SCX columns. A final replicate from 3rd approach (Exp. 4) was 
performed. (B) Venn diagram representations show the number of NEDDylated sites and 
proteins discovered in relation to the different workflow approaches. Over 1,000 
NEDDylation sites in 530 proteins were identified in total. 
 
 
NEDD8 modifies in multiple sites and regulate functionally interconnected 
proteins 
 
Fortunately, our prior analysis led us the identification of more than 1, 000 sites 
for NEDD8 which therefore can be used to compare with established mass 
spectrometry analysis for other PTMs such as for Ubiquitination and 
SUMOylation sites. For example, recent Ubiquitin and SUMO lysine modification 
analyses have demonstrated their ability to modify proteins in multiple sites (I A 
Hendriks et al., 2014; Ivo A Hendriks, D’Souza, Chang, Mann, & Vertegaal, 2015; 
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Kim et al., 2011; Tammsalu et al., 2014; Xu et al., 2010). Normally, NEDDylated 
proteins have shown the same reduce electrophoretic mobility as Ubiquitinated 
and SUMOylated proteins profiles which may indicate that conjugates also 
contain multiple modifications sites for NEDD8. In this study, we observed that 
approximately 40% (∼230) of total NEDD8R74K identified proteins had more than 
one NEDDylation site, confirming a multisite modification of NEDD8 on proteins 
(Figure 12A). Examples of >10 multisited proteins found in our data were BCLAF1 
(Bcl-2-associated transcription factor 1), AKAP12 (A-kinase anchor protein 12), 
TCOF1 (Treacle protein) and AHNAK (Neuroblast differentiation-associated 
protein AHNAK) which share a large molecular weight above 100 kDa, explaining 
the high frequency of modification. Moreover, we analyzed the Gene Ontology 
(GO) functional annotations of 494 NEDD8R74K-modified proteins with GlyGly site 
localization probability above 0.75 of the new optimized data set derived from 
NEDP1 KO cells. Related with our previous data, the GO annotation for KEGG 
pathways revealed statistical overrepresentation of proteins involved in 
complexes that regulate gene expression, translation, protein folding, actin 
cytoskeleton organization, mitotic cell cycle regulation and DNA replication, 
recombination and repair (Figure 12B). Accordingly, several ribosomal, annexin 
and heat shock proteins, RNA helicases, ribonucleoproteins and zinc finger 
proteins were frequently identified in our analysis with various NEDD8 
modifications sites. These results suggest that NEDD8 and NEDP1 directly 
regulate different groups of functionally related proteins apart from cullins. In fact, 
cullin family members were not part of the significant substrates identified in our 
data. Among all the identified sites with great localization probability parameters, 
we only found the modification of the consensus reported Lys712 on Cullin-3 
(Bennett, Rush, Gygi, & Harper, 2010; Pan et al., 2004). The low abundance 
identification of cullin proteins in this study can be explained by the limited role of 
NEDP1 to de-NEDDylate cullins (Chan et al., 2008). Another reason could be the 
minimal NEDD8 modification levels for cullin sites in comparing to its number of 
lysine residues (e.g. 68 lysines within 776 sequence length of Cullin-1), or by the 
possible formation of inaccurate MS-detectable peptides after Lys-C digestion. 
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Figure 12. Evidence for multisite modifications by NEDD8 on highly 
interconnected functional networks of proteins 
(A) Graph of the number of NEDD8R74K-modifiied sites per protein in NEDP1 depleted 
cells. (B) Overview of STRING network analysis and Cytoscape visualization of all 
identified NEDDylated proteins which had site localization probability above 0.75. 
STRING interaction confidence of 0.7 or greater was applied for data settings. MCODE 
was used to extract the most highly interconnected functional clusters from the network. 
The four highest-scoring MCODE clusters are indicated in different colors with their 
respective GO functional annotation. 
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Site modification crosstalk between NEDD8, ubiquitin and SUMO pathways 
 
NEDDylation is known to crosstalk with ubiquitination during the proteotoxic 
stress response, proposing a competition of NEDD8 with Ubiquitin for acceptor 
lysines in target proteins (Leidecker et al., 2012). In this work, we observed that 
SUMO is also overlapping with NEDDylated and ubiquitinated proteins upon 
proteotoxicity (see Figure 4). However, the extent of this crosstalk is currently 
unclear. To investigate the potential overlap between NEDD8-acceptor lysines 
with ubiquitin but also with SUMO2 lysine modifications, we extracted all known 
human MS-identified ubiquitination and SUMOylations sites from 
PhosphoSitePlus (PSP) database and compared with our NEDD8R74K data. 53% 
(∼601) and 10% (∼110) of the NEDD8R74K-identified sites overlapped with the 
ubiquitin and SUMO2 modified sites respectively (Figure 13A). In total, 635 
NEDDylated sites (55%) overlapped with ubiquitinated and SUMOylated sites in 
which 76 sites (12%) were common between the three modifiers, 525 sites (83%) 
were shared exclusively with known sites of ubiquitination and only 34 sites (5%) 
among the known SUMOylation sites. As expected, these observations suggest 
that ubiquitination and, less commonly, SUMOylation can occur on the same 
residues as NEDDylation. 
One of the main modification observed in every analysis of the NEDD8 R74K site 
identification in NEDP1 depleted cells was the NEDDylation of endogenous 
NEDD8, confirming the high regulation of NEDP1 in the formation of polyNEDD8 
chains (see Figure 8). NEDD8 has 9 internal lysines in comparison to the 7 
present in ubiquitin, which in principle indicates the potential of NEDD8 to form 
more diversity polyNEDD8 chain topology. Here, we were able to identify the 
modification of 7 lysines of NEDD8 (K6, K11, K22, K27, K33, K48 and K54) 
(Figure 13B). Of interest, NEDDylation of Lys6 and Lys11 were previously found 
in our laboratory under proteotoxic stress using a different MS strategy (Leidecker 
et al., 2012). Importantly, also in this study we observed the NEDDylation of 
ubiquitin under NEDP1 depletion by identifying the modification in all their lysines 
(K6, K11, K27, K29, K33, K48 and K63) (Figure 13B), this suggest that the 
regulation of mixed NEDD8-ubiquitin chains can be regulated by NEDP1 enzyme 
under stress conditions but also probably under homeostatic conditions. 
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Interestingly, we also found direct modification of SUMO2 by NEDD8 on lysines 
11 and 33 (Figure 13B), confirming our previous observation of the formation of 
mixed NEDD8-SUMO chains in response to proteotoxic stress by heat shock 
(see Figure 4). However, the NEDD8 modification on Lys11 was observed only 
in our previous MS analysis under MG132 treatment (CST facility) whereas the 
modification on the Lys33 was only identified in the latest NEDD8 R74K strategy 
under NEDP1 depletion (IMB collaboration). We will need further comparative 
analysis to verify if the site of modification is specific depending on the stimuli in 
the cell. So far, the major site involved in chain formation on SUMO2 and SUMO3 
is Lys11 (Tammsalu et al., 2014; Tatham et al., 2001). Nevertheless, the 
SUMOylation on Lys5, Lys7, Lys21, Lys33, Lys42 and Lys45 in SUMO2 has been 
recently reported (I A Hendriks et al., 2014; Ivo A Hendriks et al., 2015; Tammsalu 
et al., 2014). Additionally, novel strategies developed for SUMO2 sites 
identification have shown not only the SUMOylation on Ubiquitin (K6, K11, K27, 
K48 and K63) but also on NEDD8 (K48), suggesting a further complex nature of 
SUMO chain formation (Figure 13B). Besides, ubiquitination site analyses show 
that ubiquitin can modify all the lysines of NEDD8, SUMO2, and ubiquitin itself 
(as annotated by PhosphoSitePlus, Figure 13B). Unquestionably, these findings 
propose that the mixed-chain formation between ubiquitin and ubiquitin-like 
family members is more common than previously thought which suggest a higher 
complexity code of modification.  
Crosstalk between NEDDylation and ubiquitination includes the direct regulation 
of enzymatic components of the respective pathways. For example, we could 
observe the modifications of UBA3, NAE1, UBE2M, UBE2F and DCN1-like 
proteins, which are members of the NEDD8 conjugation machinery. This 
observation suggests that they may undergo autoNEDDylation regulated by 
NEDP1 (see Figure 8). We also found the direct modification of the cellular factor 
NUB1, which, besides the de-NEDDylating enzymes, negatively regulates the 
protein levels of NEDD8 and NEDDylated substrates (T. Kamitani et al., 2001; 
Liu et al., 2013). Furthermore, we identified the modification of ubiquitin protein 
ligases, ubiquitin proteases and general regulators of the ubiquitination process, 
such as UBA1, USP5, RNF20, CAND1 and VCP (Figure 13C-D), indicating a 
broader crosstalk between NEDDylation and ubiquitination pathways apart from 
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cullins and proteotoxicity-associations. Evidence of SUMOylation of components 
of the ubiquitination machinery (I A Hendriks et al., 2014; Tammsalu et al., 2014) 
suggest that these ubiquitin family members directly regulate each other. 
However, until now no evidence of direct modification has been shown between 
enzymatic components for NEDDylation and SUMOylation which indicates a less 
interconnection between their pathways. 
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Figure 13. Croostalk between NEDD8, SUMO2 and ubiquitin modifications 
(A) Venn diagrams showing the overlap of the identified NEDDylated lysines in this study 
with the respective ubiquitinated and SUMOylated lysine sites identified in other studies 
using MS as annotated in the PhosphoSitePlus database. (B) Sequence alignments of 
the reported and newly identified lysines (K) modified by NEDDylation (blue), 
SUMOylation (green) and Ubiquitination (red) on human NEDD8, SUMO2 and Ubiquitin, 
respectively. The lysines marked in grey are yet not identified as NEDDylated, 
SUMOylated or Ubiquitinated sites. The ruler indicates until 70-amino acid length of the 
sequence of the respective proteins. (C) NEDDylation and ubiquitination are highly 
interconnected. STRING-network analysis and Cytoscape visualization shows that 
potentially NEDD8 directly modifies and regulate proteins related to the NEDDylation 
pathway itself but also to more diverse members of the Ubiquitination pathway beyond 
cullins. (D) Table representation indicating the NEDDylated proteins and sites identified 
in our NEDP1 KO cells (localization probability above 0.75) to the respective 
NEDDylation or ubiquitination-related network. 
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Evidence of NEDDylation consensus motif on non-cullin substrates 
 
Cullins are the best-defined NEDD8 substrates. NEDDylation on cullins (CUL1, 
2, 3, 4A, 4B, 5, 7 and PARC), is known to occur on the carboxyl-terminal 
consensus motif (IVRIMKMR) (Bennett et al., 2010; Enchev et al., 2014; Pan et 
al., 2004) (Figure 14A). With the identification of new NEDD8 sites, our dataset 
provides an opportunity to obtain further insight into NEDDylation sequences to 
investigate a possible NEDD8 modification motif for non-cullin substrates. Here, 
we selected NEDP1 regulated NEDD8R74K sites with a GlyGly-ε-Lys localization 
probability above 0.9 (758 sites) to examine the NEDDylated protein sequences 
using pLogo (O’Shea et al., 2013) and iceLogo (Colaert et al., 2009) for statistical 
analysis. Overall, both analyses revealed a significant overrepresentation of (i) 
Met six amino acids C-terminal to the conjugated Lys (position −6), (ii) of residues 
Ala or Asn at position −2, (iii) of the hydrophobic residue Leu at position −1, (iv) 
of residue Gly at position +1, (v) of residue Pro at position +2 and, (vi) the acidic 
residue Asp at position +5. In contrast, NEDDylated peptides were deficient in 
histidines, arginines and, most notably, cysteines (Figure 14B). This observation 
of reduced frequency of cysteines around modified lysines is also consistent with 
ubiquitinated and SUMOylated regions, which is proposed to prevent the 
formation of thioesters between the modifiers and target proteins (I A Hendriks et 
al., 2014). Interestingly, the NEDDylated regions were enriched with lysines and 
are therefore easily exposed for modification. The only particular similarity shared 
with the cullin-consensus motif is certain tendency to have a Lys residue in 
position +3. In conclusion, the sequence context analysis of NEDD8 
modifications sites exhibit a potential existence of a consensus motif for cullin-
independant NEDDylation. 
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Figure 14. Sequence analysis of NEDD8R74K – modified peptides 
Sequence logo (pLogo) and heat-map graphs (iceLogo) of amino acid sequence 
conservation surrounding NEDD8-modified sites. (A) Sequence representation of the 
reported cullin consensus motif for NEDDylation from 6 members of the cullin family 
(CUL1, 2, 3, 4A, 4B and 5) (B) Sequence representation of the analysis of 758 
NEDD8R74K-modified sites (from the ∼1,100 total identified) which had localization 
probability above 0.9. Threshold values of 3.68 (P <0.05) are shown in red and marked 
with red horizontal lines for logo graphs. 
 
 
 
 
 
 91 
Insight into the cullin-independent role of NEDD8 in DNA damage response 
 
The functional annotation analysis of the total NEDDylated proteins found in this 
study upon NEDP1 depletion and proteotoxicity suggested that NEDD8 has a 
broader direct role, besides CRL regulation, in controlling a network of proteins 
involved in cellular processes such as cell cycle and DNA damage response 
(DDR) (see Figure 10F and 12B). It is well established that an accurate and 
efficient DDR requires the recruitment of post-translational modifications on a 
complex group of proteins. Ubiquitin and SUMO have important functions in the 
cellular response to DNA double-strand breaks (DSBs). Moreover, the crucial role 
of NEDD8 in DNA repair processes is now emerging (Brown & Jackson, 2015). 
Unquestionably, the irreversible NEDDylation inhibitor MLN4924 have shown 
how the prolonged inhibition of CRL activity and subsequent accumulation of CRL 
substrates, specially the stabilization of CDT1 through CRL4CDT2 inhibition, leads 
to S-phase arrest and DNA re-replication resulting in DNA damage and eventual 
cellular apoptosis (Blank et al., 2013; Lin, Milhollen, Smith, Narayanan, & Dutta, 
2010). Proliferating cell nuclear antigen (PCNA) is an essential replication 
protein, which also coordinates multiple DNA damage response pathways. 
Exposing cells to DNA-damaging agents such as ultraviolet (UV) irradiation 
commonly results in the modification of PCNA by ubiquitin or ubiquitin-like 
modifiers including SUMO and ISG15, which eventually regulates the recruitment 
of different proteins to the stalled replication fork (Cipolla et al., 2016). Here, we 
identified PCNA as a potential protein directly modified by NEDD8. Based on this 
result, we tested if we could find specific differences in PCNA modification during 
UV-induced DDR in our NEDP1 depleted cells. First, we observed that NEDP1 
KO cells are deficient in both mono and poly-modify PCNA during DNA damage 
response when cells are arrested in S-phase and having DNA re-replication from 
prolonged treatment (15 hours of 500nM) with the inhibitor MLN4924 (Figure 
15A). After 6 hours of UV recovery, PCNA displayed high levels of poly-
modification, while in NEDP1 depleted cells this modification was significantly 
decreased (Figure 15B). Secondly, when we blocked cells in G1/S-phase using 
double-thymidine treatment (2.5 mM) and, subsequently, expose cells to UV 
irradiation (10 J/m2) we obtained the same reduced modification pattern of PCNA 
in the NEDP1 depleted cells. The lower levels of mono and poly-modification of 
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PCNA were observed during the late DNA damage response (between 9 and 12 
hours after exposure). This indicates a potential role in the repair process. 
Interestingly, NEDP1 expression increases during the response to DNA damage 
especially from 6 hours after UV irradiation which remains stable until 24 hours 
when cells are recovered from damage. (Figure 16A). In addition, FACS analysis 
demonstrated that the fraction of cells in G1 decrease drastically after 9 hours of 
exposure when compared to the control cells. In contrast, the fraction of NEDP1-
depleted cells in G2 increase greater than in NEDP1 expressing cells, more 
notably, during the late DNA damage response. This observation suggests that 
the NEDP1-depleted cells resume the cell cycle faster than the wild-type cells, 
indicating also that NEDD8 might have a direct role in cell cycle checkpoint 
regulation after DNA damage (Figure 16B-C). In agreement with our findings, we 
validated that NEDD8 directly modifies PCNA and histone proteins (H2B) 
regulated by NEDP1, which are essential proteins in the DNA damage response 
after DSBs (Figure 16D). Further analyses are necessary in order to elucidate the 
function of NEDP1 in regulating the NEDDylation of CRL-independent substrates 
important for cellular stress responses such as during DNA damage. 
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Figure 15. NEDP1 regulates the post-translational modification of PCNA during 
DNA damage response 
(A) Flow cytometric analysis of DNA content of control and NEDP1 depleted HCT116 
cells which shows the S-phase arrest and re-replication phenotypes resulting after 15 
hours of MLN4924 treatment. (B) Control and NEDP1 depleted cells pre-treated with 
MLN4924 (500nM) for 15 hours and subsequently exposed to ultraviolet (UV) irradiation 
(15 J/m2) were collected for the indicated times for immunoblot analysis with PCNA, p53 
and NEDD8 antibodies respectively. 
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Figure 16. NEDP1 responds to DNA damage affecting cell cycle and the 
modification of PCNA in S-phase arrested cells 
(A) Control and NEDP1 depleted HCT116 cells were double treated with thymidine (2.5 
mM) and exposed to ultraviolet (UV) irradiation (10 J/m2). Cells recovering for the 
indicated times were collected and lysates were blotted for PCNA, p53 and NEDP1, 
respectively. (B) Propidium iodide-stained cells from each time point were analyzed by 
flow cytometry. (C) Schematic comparison of the percentage of cells in the respective 
cell cycle checkpoint (G1, S-phase and G2) from the different time points presented in 
the control and NEDP1 depleted cells after double-thymidine block and UV recovery. (D) 
Western blot analysis of whole cell extract (WCE) and chromatin extract from wild-type 
or NEDP1-depleted HCT116 cells stably expressing 6His-NEDD8WT construct. 6His-
pulldown (Ni-NTA) was performed, afterwards PCNA (left) and H2B (right) were detected 
for NEDD8 (N8) modification. 
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DISCUSSION 
 
Atypical NEDDylation: the NEDD8 response to proteotoxic stress 
 
The NEDD8 proteome is mechanistically and functionally divided into two groups: 
the atypical (UBE1) and canonical (NAE) dependant. In this study, we developed  
SILAC-based proteomic strategies to characterize the global dynamic of the 
human NEDDylome according to these distinct modes of activation. We 
performed a lentiviral infection approach to stable express a 6His-NEDD8 
transgene at endogenous levels, assuring the NEDD8: ubiquitin balance during 
homeostasis. In consequence, our studies on the NEDDylation state changes 
lead to a valid biological response. To investigate the atypical NEDDylation 
response, we applied hyperthermic stress and isolated the 6His-NEDD8 
conjugates for MS analysis. We observed that heat shock strongly increased the 
atypical NEDD8 modification of ubiquitin and SUMO 1/2 modifiers. Hence, our 
findings suggest that the crosstalk between NEDD8, ubiquitin, and SUMO is the 
main phenomenon throughout proteotoxic stress. Consistent with the knowledge 
that NEDD8 is activated by the ubiquitin machinery during proteotoxicity leading 
to mixed NEDD8-ubiquitin chain formation (Hjerpe, Thomas, Chen, et al., 2012; 
Leidecker et al., 2012), it was not surprising to see the great increase of ubiquitin 
modification by NEDD8 upon heat shock (HS). However, SUMO1/2 proteins 
appeared even more NEDDylated upon this condition. This observation highly 
correlates with the fact that SUMO has a vital role for thermal stress response by 
substantially forming polySUMO chains (Častorálová et al., 2012; Golebiowski et 
al., 2009). Hence, our findings imply that mixed NEDD8-ubiquitin but also 
NEDD8-SUMO chain are extensively forming in proteotoxic conditions driven by 
atypical NEDDylation. 
 
One of the interrogatives that are not entirely understood is about the precise 
cellular mechanism of atypical NEDDylation. Previous studies indicate that the 
ubiquitin-activating enzyme UBE1 has reduced kinetics to activate NEDD8 in vitro 
in comparison to the NEDD8-activating enzyme NAE (Whitby et al., 1998). 
Acoordingly, the increased levels of NEDD8 over ubiquitin is enough to trigger 
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this activation in vivo (Hjerpe, Thomas, Chen, et al., 2012; Hjerpe, Thomas, & 
Kurz, 2012). Besides, it is well documented that the free ubiquitin pool is limited 
in the cell. Although ubiquitin is highly expressed, it seems that the majority is 
either conjugated or in the process of being conjugated for the regulation of 
proteolysis and other cellular processes (Dantuma, Groothuis, Salomons, & 
Neefjes, 2006; Dantuma & Lindsten, 2010). Thus, proteotoxic stress results in a 
dramatic depletion of the levels of free ubiquitin due to the increase in the 
accumulation of polyubiquitinated proteins. We assume that the ubiquitin limiting 
factor is the most important mechanism that initiates the NEDD8 atypical 
activation but also that there must be other determinants that cooperate for this 
response to occur. In the laboratory, we examined that the increase of 
NEDDylation upon proteotoxicity is not related to newly synthesize NEDD8 (data 
not shown). This observation indicates that upon proteotoxic stress the cell is 
changing the fate of the existent free NEDD8 pool by (i) increasing its levels, (ii) 
reducing the competition with ubiquitin for the E1 activating enzyme and finally, 
(iii) modifying substrates through the ubiquitin machinery. Interestingly, we also 
identified the NEDD8 E1 regulatory subunit NAE1 (APPBP1) as one of the 
NEDDylated substrates increasing during HS response. In contrast, members of 
the cullin family significantly decrease in NEDDylation upon HS. It appears that 
this thermal stress condition induces the autoNEDDylation of NAE1 which could 
result in a reduced activity of the NAE enzyme. Therefore, NEDD8 is not 
efficiently activated by its cognate pathway and compromises the basal 
modification of cullins. Probably, the limiting modification of cullins is increasing 
the levels of free NEDD8 but also is helping to diminish the ubiquitination of CRL 
substrates and in consequence, ubiquitin is used for other stress-related 
purposes. Likewise, we identified the increase in NEDDylation of the histone 
protein H2B upon heat shock. Our finding coincides with the reduction of the 
levels of monoubiquitinated histone H2A in thermally shocked cells observed in 
previous studies (Dantuma et al., 2006). Interestingly, similar results have been 
shown for canonical SUMO target proteins including RANGAP1 which are no 
longer SUMOylated in response to stress (I A Hendriks et al., 2014). Together 
with the induction of ubiquitin synthesis and the disassembly of ubiquitin chains 
(Crosas et al., 2006; Fornace Jr, Alamo Jr, Hollander, & Lamoreaux, 1989; 
Kimura et al., 2009), it seems that the atypical NEDDylation is another important 
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cooperative function for increasing ubiquitin availability when is highly demanded 
such as during proteotoxic stress. Given that the UPS dysfunction induced upon 
proteotoxicity is related exclusively for the ubiquitin-dependent substrates (Kelly, 
Vanslyke, & Musil, 2007; Salomons et al., 2009), the limitation of free ubiquitin 
has a significant impact on the cell response and recovery after stress. 
Furthermore, time is another ultimate critical factor to overcome stress. The 
proteotoxic stress-induced “replacement” of ubiquitin with NEDD8 might be a 
favorable cellular mechanism because (i) is a fast and efficient process which 
take advantage of the closest similarity of the modifiers, (ii) the cell saves energy 
by shifting the activation through one pathway machinery, (iii) is reversible and 
gives the possibility to recover from this atypical situation. 
 
Outcome of the atypical NEDDylation into the ubiquitin code 
 
Given that NEDD8 can cross the barrier of the ubiquitin enzymes during 
proteotoxic stress, this bears a fascinating enigma concerning the potential 
biological consequences. Either atypical NEDDylation is a new signal necessary 
for stress response factors, or simply NEDD8 is mimicking ubiquitination. The 
truth is that proteins which are usually ubiquitinated, suddenly they are instead 
getting NEDDylated and this potentially can change the signaling fate of the 
substrates. Significantly, in our SILAC results, we observed that NEDD8 is 
altering the topology of both polyubiquitin and polySUMO chains. This NEDD8 
"editing" is a critical event giving the existence of adaptor proteins which use 
specific binding domains to recognize these modifications for essential cellular 
functions (Husnjak & Dikic, 2012). Therefore, the formation of mixed NEDD8-
ubiquitin and NEDD8-SUMO chains are likely (i) affecting the rate of recognition, 
(ii) abolishing the binding or (iii) creating a new code for distinct downstream 
effects. A well-established link between different modification pathways and 
binding recognitions is the evidence of the ubiquitin-SUMO crosstalk. SUMO-
targeted ubiquitin ligases (STUBLs) attach ubiquitin chains to proteins that are 
already polySUMOylated (Geoffroy & Hay, 2009; Prudden et al., 2007; Uzunova 
et al., 2007). The SUMOylation is a signal for the recruitment of the STUBLs 
through the binding affinity with SUMO-interacting motifs (SIMs), then the 
resulted ubiquitination mediates proteasome degradation of the modified 
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proteins. These type of ligases, such as RNF4, are implicated in several signaling 
pathways, including protein quality control and cellular responses to arsenic 
poisoning and DNA damage (Guo et al., 2014; Tatham et al., 2008; Yin et al., 
2012). By having atypical NEDDylayion, if NEDD8 modifies a SUMOylated 
protein prior the recognition by a particular STUBL thus is possible that it will be 
no longer a target for ubiquitination. Alternatively, if a ubiquitin ligase like the 
STUBLs adds mixed NEDD8-ubiquitin or polyNEDD8 chains instead of 
polyubiquitin chains, then the further recognition and degradation by the 
proteasome can be somehow affected or recognized by different cellular surface 
receptors. Indeed, it has been shown that NEDD8 binds more weakly to the 
proteasomal ubiquitin receptor Rpn10 (Singh et al., 2012). Moreover, several 
NEDD8-interacting proteins have been reported such as the NEDD8 Ultimate 
Buster 1 (NUB1) and its splicing variant NUB1L. NUB1 contains UBA domains 
that bind to NEDD8 and, therefore promotes the transfer of NEDDylated 
substrates for proteasomal degradation (T. Kamitani et al., 2001; Kito, Yeh, & 
Kamitani, 2001; Tanaka, Kawashima, Yeh, & Kamitani, 2003). However, unlike 
for ubiquitin and SUMO, not yet specific binding motifs for NEDD8 has been 
identified. In fact, some of the domains of NEDD8-interacting proteins have 
shown affinities for NEDD8 in the similar µM range as for ubiquitin (Enchev et al., 
2014). Thus, our findings confirm the high crosstalk and complexity regarding the 
ubiquitin-like proteins modifications, especially between NEDD8 and ubiquitin, 
which remain poorly understood. Further studies are needed to examine 
enzymes, substrates, interfaces with distinct specificities and functions for a 
particular type of modification of the expanded ubiquitin code. Our SILAC 
approach on atypical NEDDylation provides reliable information on the outcome 
of NEDD8 proteome during stress. Nevertheless, it does not reveal the form of 
linkage of the target protein. Previous diglycine remnant-base quantitative 
proteomics upon proteasome inhibition have shown that this mixed NEDD8-
ubiquitin modification is primarily occurring via the K48 linkage which correlates 
for proteasomal degradation (Kim et al., 2011). For future research, it will be 
interesting to explore the composition and form of linkages in chains topology 
leading by stress responses. 
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Role of NEDD8 in nuclear aggregation during proteotoxicity 
 
Proteins face constant structural dynamic and their proper integrity is pivotal for 
cellular function and survival. Protein folding is intrinsically an error-prone 
process. Consequently, cellular stress conditions induce the accumulation of 
misfolded proteins which exposure of hydrophobic residues leads to the 
formation of insoluble aggregates (Alam et al., 2017; Balchin, Hayer-Hartl, & 
Hartl, 2016). Protein aggregation has been linked to both cytoprotective and toxic 
effects depending on the stress induction, the composition of the sequestered 
proteins and the type of aggregation ultimately formed. Therefore, the active 
organized control of aggregated proteins is necessary for the maintenance of 
proteome homeostasis (proteostasis) (Miller, Mogk, & Bukau, 2015). Efficient 
protein quality control (PQC) systems ensure proteostasis toward promoting 
refolding by chaperones or via proteolytic degradation either through the 
ubiquitin-proteasome system (UPS) or autophagy (B. Chen et al., 2012). Here, 
we characterized that upon proteotoxic stress NEDD8 promotes the translocation 
of aggregates from the cytosol to the nucleus together with ubiquitin and SUMO. 
Interestingly, by comparing from atypical and canonical NEDDylation, we found 
that atypical NEDD8-mediated nuclear aggregation is mainly composed of 
ribosomal proteins but also of proteins related to the endoplasmic reticulum, RNA 
transport, aminoacyl-tRNA biosynthesis and proteasomes. Because of the 
protein composition within these nuclear aggregates regulated by NEDD8, we 
could appreciate the link with protein synthesis and proteasome proteolysis. 
Indeed, protein synthesis is a complex multistep process highly coordinated and 
regulated by the UPS, involving diverse mechanisms in several subcellular 
compartments, from nucleolus in the nucleus to endoplasmic reticulum in the 
cytoplasm (Amm, Sommer, & Wolf, 2014). Ribosomes are the central factory for 
protein synthesis and the ribosome biogenesis iltself involves the organized 
assembly of ribosomal RNA (rRNA) with almost 80 ribosomal proteins (RPs) 
(Kressler, Hurt, & Baßler, 2010). Moreover, a major challenge is that the cell 
needs equimolar amounts of rRNA and RPs for the precise production of 
ribosomal subunits to form the ribosomes. Studies suggest that substantial 
excess of RPs are produce over rRNA. Therefore, once synthesized, RPs are 
rapidly imported into the nucleus for degradation by the UPS which careful 
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regulation is essential for cell physiology (Rudra & Warner, 2004; Sung et al., 
2016; Warner, 1999; Wójcik & DeMartino, 2003). Still is unclear how the cell 
manages to recognize and degrade the accurate number of unassembled RPs. 
Interestingly, SUMO proteins are known to be involve in controlling the rate of 
ribosome biogenesis (Finkbeiner, Haindl, & Muller, 2011).  NEDDylation of RPs 
were identified previously in the laboratory (D. P. Xirodimas et al., 2008) and in 
this study, we could validate the direct NEDD8 modification of ribosomal proteins 
(RPL7 and RPL11) upon proteotoxicity. Given that atypical NEDDylation is mainly 
involved in the modification of inherent unstable newly synthesized proteins (data 
not shown), we hypothesize that during stress the majority of NEDD8 substrates 
are nuclear-misfolded proteins already destined for this compartment, such as 
the RPs. Furthermore, because UPS proteolytic capacity is importantly needed 
in stress situations, it is possible that NEDD8-mediated nuclear aggregation is 
avoiding nuclear and, most notably, cytosolic UPS impairment. The formation of 
mixed NEDD8-ubiquitin and NEDD8-SUMO chains by atypical NEDDylation can 
potentially alter the recognition and final processing of substrates by the 
proteasome. The remain question is: why NEDD8 specifically promote the 
nuclear aggregation of proteins implicated on ribosomes, translation, and 
proteasomes during the stress? According to the UPS “protective” hyphotesis, 
we can expeculate for ribosomal proteins that their excess synthesis and 
degradation will potentially induce rapid and severe cellular proteotoxicity by 
overloading proteasomes. Then, after stress either they are (i) removed by 
nuclear proteasomes, (ii) exported to the cytosol for UPS or autophagic 
degradation or (iii) eliminated by disassembly of the nuclear envelope during 
mitosis. On the other hand, given the ring-like structure of the aggregates 
observed after prolonged stress, another possibility is that this “sequestration” of 
proteins protects them from severe damage and provides correct function once 
the cell is alleviated. The reversible mechanism of active re-solubilized 
aggregates is supported by recent studies which, interestingly, coincide with our 
finding of aminoacyl-tRNA synthetase related proteins aggregating upon heat 
stress (Wallace et al., 2015). This process reflects a powerful adaptation of 
eukaryotes to recover and survive from stresses such as thermal damage. 
Considering that the balance of ribosomal proteins is a key factor for proteostasis, 
their NEDDylation and further nuclear aggregation in response to stress can 
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represent a mechanism which ensures an effective cellular recovery. It makes 
sense as an evolutionary adaptation from stress to protect and reuse ribosomes 
and proteasomes for overcoming de novo biogenesis. Because the assembly of 
these complex types of machinery is massive in time and energy consumer, their 
up-regulation synthesis after stress will have substantial repercussions on the 
expression, synthesis, and regulation of other crucial proteins which were 
damaged or lost during the stress. Our studies do not offer knowledge on the 
mechanism of aggregation driven by NEDD8, ubiquitin, and SUMO but it gives 
new evidence of the identity of the induced aggregated proteins during stress for 
further study. We hypothesized that the intrinsic nuclear localization and low 
thermodynamic stability of NEDD8 over ubiquitin (T. K. Kamitani et al., 1997; 
Kitahara et al., 2006) are partially promoting the unfolding properties of the mixed 
NEDD8-ubiquitin chains and thus providing an auxiliary signal for the aggregation 
of nuclear proteins. These scenarios on atypical NEDDylation help to explain the 
purpose of most eukaryotes to conserve such similar proteins to ubiquitin such 
as NEDD8. 
 
NEDP1 maintains the canonical NEDDylation for cellular proteostasis 
 
It is evident that the homeostatic activation of NEDD8 by its genuine E1 enzyme 
(NAE) is mainly limited to the modification of cullins for the regulation of the cullin-
RING ubiquitin ligases (CRLs). Also, the cellular proteostasis sustains a steady-
state of the free NEDD8 pool. Given the dynamic role of NEDD8 to enter into the 
ubiquitin pathway, it is evident the importance to regulate the balance of NEDD8 
and ubiquitin pool to maintain cellular proteostasis. In this study, we aimed to 
understand the role of canonical NEDD8 conjugation beyond cullins by analyzing 
the function of the specific protease NEDP1 due to its noted potential to regulate 
non-cullin NEDDylation targets. We determined the global NEDDylation changes 
derived from the depletion of NEDP1 by using SILAC quantitative proteomics in 
CRISPR/Cas9-derived knockout cells (NEDP1 KO). Our proteomic analysis 
revealed the significant function of NEDP1 to regulate the NEDDylation of 
NEDD8 itself, and components whitin the NEDD8 pathway including the E1 
subunits NAE1 (APPBP1) and UBA3 (UBE1C), as well as the E2 enzyme UBE2M 
(Ubc12). Most of the proteins we identified were also found in recent NEDP1 KO 
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quantitative MS analysis of NEDD8 conjugates which confirms and strongly 
validate these novel NEDD8 substrates regulated by NEDP1 (Coleman et al., 
2017). Unquestionably, polyNEDDylation together with the depletion of free 
NEDD8 is part of the main consequences of NEDP1 depletion. It is unclear the 
biological implications of the dramatic increase of polyNEDD8 conjugation given 
that the chain accumulation itself is not lethal and does not lead to a prominent 
cell phenotype. Therefore, according to the dynamic of atypical NEDDylation 
during stress and the evident role of NEDP1 in maintaining NEDD8 homeostasis, 
it appears that the unavailability of free NEDD8 due to the accumulation of 
polyNEDD8 chains will be strongly crucial for cell survival upon proteotoxic stress 
response. This NEDD8 modification of the enzymes is by an autoNEDDylation 
process given their conjugation observed in an E1-E2-E3 step independent 
manner in vitro (Mergner, Kuster, & Schwechheimer, 2017). Furthermore, it could 
be that the outcome of polyNEDD8 modification is either (i) to compete with other 
post-translational modifications, (ii) to interfere with protein-protein interactions, 
(iii) to alter proteins functionality or (iv) to give a signal for a precise function. For 
example, the autoNEDDylation of the E1 NAE subunits (NAE1 and UBA3) have 
shown decrease transfer efficiency of the activated NEDD8 to the E2 UBE2F in 
plant homologs by the progressive reduction of the NAE activity (Mergner et al., 
2017). Additionally, the NEDD8 auto-modification of the E2 UBE2M relatively 
reduced its binding with the E3 NEDD8-ligase DCN1 which shows the 
repercussion for protein interactions (Coleman et al., 2017). Interestingly, another 
common identification was observed for the decreased of only one member of 
the cullin family (CUL5) in NEDP1-deficient cells which NEDD8 modification is 
almost exclusively triggered by the E2 enzyme UBE2F over UBE2M (Huang et 
al., 2009). However, the decrease of CUL5 modification was not due to the 
autoNEDDylation of UBE2F and resulted misfunction, but instead due to the 
decline in the total protein levels of the UBE2F enzyme (Coleman et al., 2017). 
This finding suggests a different proteolytic role of the autoNEDDylation of 
enzymes or the polyNEDD8 accumulation of other substrates controlled by 
NEDP1, but the exact mechanism will need to be elucidated. In contrast with 
recent observations in plants (Mergner et al., 2017), our quantitative NEDP1 KO 
experiment suggest a preference for NEDD8 to covalently conjugate UBA3 
subunit than NAE1 subunit. Therefore, we will need to validate this finding in vitro 
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and to study the inherent functional relevance of this dynamic in vivo for human 
cells. All this data implies that NEDP1 recovers NEDD8 moieties from conjugated 
proteins and, most notably, from the autoNEDDylation of the NEDD8 conjugation 
machinery. By inhibiting the accumulation of NEDDylated substrates, NEDP1 is 
not only regulating the free NEDD8 pool which limitation can be critical in a 
cellular stress context, but also is coordinating the proper functionality of the 
NEDD8 machinery to maintain the steady-state NEDDylation during 
homeostasis. Similar recycling functions have been observed for some 
deubiquitinating enzymes (DUBs) during ubiquitin-dependant degradation by the 
26S proteasome (Reyes-Turcu et al., 2009). Nevertheless, it is clear that even 
the autoNEDDylation of the NEDD8 machinery affects their conjugation activity 
throughout NEDP1 depletion, this enzymes misfunction does not lead to a 
dramatic effect on all cullins NEDDylation. Accordingly, NEDP1 KO does not 
mimic the substantial effect on NAE as the inhibitor MLN4924 which blocks the 
activation of all CRLs. This observation reflects a substrate-specific effect of 
NEDP1 KO as it was shown recently through the COP9 signalosome (CSN) 
inhibition which likewise only affected the stability of specific CRL substrates. 
Interestingly, this deNEDDylation-independent activity of some CRL complexes 
is due to a sustained auto-ubiquitination of certain substrate recognition modules 
(Schlierf et al., 2016). Furthermore, our SILAC analysis identified other NEDD8 
pathway-independent proteins that increase in NEDP1 KO cells such as the E3 
ubiquitin-ligase UBE3C, the nucleolar protein NOP14, the glycerol-3 phosphate 
acyltransferase 3 AGPAT9 (GPAT3) and the zinc finger protein ZNF646. These 
new potential non-cullin substrates for NEDD8 are mainly nuclear involved in 
subcellular translocation, transcription and UPS proteolysis which strongly 
correlates with our observations in the overall outcome of atypical NEDDylation. 
In conclusion, our findings on atypical and canonical NEDDylation provide broad 
evidence of the biology of NEDD8 conjugation besides CRL regulation which 
remains largely unexplored. 
 
NEDDylome and its specific modification sites  
 
System-wide proteomics is a powerful tool to study the outcome of post-
translational modifications (Mann & Jensen, 2003). Nowadays, MS-based 
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proteomics and bioinformatics advantages have reported thousands of 
substrates and modification sites for ubiquitination and SUMOylation (Ivo A. 
Hendriks & Vertegaal, 2016; Kim et al., 2011; S. a. Wagner et al., 2011). With the 
aimed to expand the knowledge of the role of NEDDylation, in this work we 
developed a MS-based strategy for the large-scale identification of novel 
substrates and sites from NEDD8 modification. By using a 6His-NEDD8 R74K 
mutant and the highly selective Lys-ε-GG antibodies, we were able to isolate and 
identify for the first time more than 1,000 specific NEDDylation sites in 
approximately 500 conjugates from human cells. Several of the NEDD8-
conjugated proteins we identified were also found in previous and recent 
analyses using ectopically-expressed NEDD8 wild type (Jones et al., 2008; D. P. 
Xirodimas et al., 2008) or NEDD8 L73P mutant (Coleman et al., 2017), which 
strongly confirms our findings for NEDD8 proteome. The principal advantage of 
our strategy is that not only we could avoid artificial effects of exogenous NEDD8 
overexpression (Hjerpe, Thomas, Chen, et al., 2012), but also the replacement 
of trypsin for Lys-C endoproteinase provide us specific diglycine remnants from 
NEDD8 modifications thus excluding from ubiquitination and ISG15ylation. 
Therefore, these features allow us to detect many common and new conjugates 
and sites for NEDD8 which considerably extends the understanding of the 
NEDDylome. As a first approach, we used Ni-NTA affinity purification to isolate 
6His-NEDD8 R74K conjugates prior diglycine immunoprecipitation either from 
MG132 treated cells or CRISPR/Cas9-NEDP1 depleted cells. Clearly, we 
perceived a weaker identification of substrates and sites from the conjugates 
upon proteasome inhibition than NEDP1 KO. The possibilities are either the 
atypical NEDDylation is limited to form mixed chains with ubiquitin and SUMO 
and modify certain substrates such as histones and ribosomal proteins, or the 
R74K mutation is affecting the recognition and further activation by the UBE1 
enzyme. Previous mutagenesis analysis in NEDD8 and ubiquitin have shown the 
existence of key residues, most notably residue 72, to be critical for the activation 
and discrimination between the modifiers by their respective cognate E1 
enzymes (Bohnsack & Haas, 2003; Walden et al., 2003; Whitby et al., 1998). This 
observation indicates that the structure is essential for E1 enzymes to recognize 
and activate the precise substrate. Even lysine and arginine residues have 
positive-charged side chains we do not know in which extent the differences in 
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their side chains might affect the final folding of the protein. Nevertheless, the 
mutation itself does not seem to affect the activation and final conjugation of 
substrates as we could identify multiple modification sites, especially in NEDP1 
KO cells. Surprisingly, we identified many shared proteins within the atypical and 
canonical NEDD8 activation. Although specific substrates were found from 
proteasome inhibition and NEDP1 depletion, the proteome biological outcome 
was almost the same including processes such as chromatin assembly, RNA 
binding, and actin regulation which correlates with the implied role of NEDD8 in 
nuclear functions and protein transport. Similarly, among the shared conjugates, 
proteins were implicated in functions including chromatin organization, RNA 
processing, and DNA damage response as well as the NEDDylation pathway 
itself. Accordingly, our findings strongly suggest the role of NEDD8 in controlling 
these processes in both homeostasis and stress conditions. However, more 
differences appeared regarding the modifications sites within the shared proteins 
in both conditions. Therefore, this remark opens the question if NEDD8 compete 
with ubiquitin for the same substrates but not necessarily for the same sites of 
modification. Interestingly, concerning the modification of ubiquitin and SUMO 
modifiers, we identified the modification of ubiquitin in K63 only under NEDP1 
depletion, in contrast, the modification of SUMO in K11 was found exclusively 
under proteasome inhibition. The disadvantage of our study is that we can not 
conclude these variations in the modification sites without an accurate 
quantitative analysis comparing both atypical and canonical NEDDylation. 
Hence, one of our proximal directions to investigate is with the aim to clarify this 
interrogation about NEDD8 and ubiquitin crosstalk. 
 
System-wide analysis of the canonical NEDDylation substrates and sites 
 
In our second approach for the NEDD8 R74K workflow, we performed stringent 
peptide purification instead of Ni-NTA isolation upon the conjugates from NEDP1 
KO cells. Our central purpose was to broader examine on the apparent unknown 
canonical NEDDylation substrates besides cullins. This workflow optimization 
greatly increased the identification of NEDD8 sites for up to 1,000. The gain of 
substrates and site identification allowed us to explore the NEDDylation outcome 
in a system-wide level through bioinformatics. We could proof the ability of 
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NEDD8 to modify proteins in multiple sites as it was observed previously for 
ubiquitin and SUMO (Ivo A Hendriks et al., 2015; Kim et al., 2011; Tammsalu et 
al., 2014). Unfortunately, the GG remnant procedure is unable to determine 
whether the multiple modifications can occur simultaneously. Therefore, it exists 
the possibility that during crosstalk either the modifiers compete promiscuously 
for the lysine residues within substrates or that they modify a protein 
simultaneously in different sites. Furthermore, we performed protein interaction 
analysis to visualize the functional interconnectivity of NEDD8 substrates. Major 
protein correlation was observed in processes involve in mRNA splicing, 
translation, protein folding, cell cycle regulation and DNA damage response. 
Interestingly, the majority of these functions are also highly related to 
SUMOylated proteins. Indeed, whereas ubiquitin is throughout the cell, NEDD8 
and SUMO are predominantly nuclear proteins (T. K. Kamitani et al., 1997; Saitoh 
& Hinchey, 2000). In consequence, it is likely that the occurrence of crosstalk for 
NEDD8 and SUMO during homeostasis is greater than expected as we observed 
under stress conditions. Importantly, about 50% of our NEDDylation site 
database overlapped with the ubiquitination and SUMOylation site databases 
annotated in PhosphositePlus (Hornbeck et al., 2012). As expected, the greater 
amount of the overlapped sites corresponded to the reported ubiquitination sites. 
Nevertheless, this ubiquitination identified sites are underestimated given that the 
tryptic GG remnant technique does not exclude if it was also a NEDDylation or 
ISG15ylation modification site. Then, our analysis could mean that within the 
∼50% sites overlapping with ubiquitination sites they can be certainly modified by 
both proteins or exclusively by NEDD8 but not by ubiquitin. Strikingly, the other 
∼50% of the identified NEDDylation sites not overlapping could represent unique 
NEDD8 modification sites. Likewise ubiquitin and SUMO proteins, it has been 
shown that NEDD8 is able to form chains (Leidecker et al., 2012; Singh et al., 
2012). Another apparent limitation of the GG remnant analysis is that it does not 
report whether the target site was mono- or poly modified by the nine possible 
isopeptide-based chain linkages of NEDD8. This lack of information is an 
important issue since our data could confirm the ability of NEDD8 to modify 
multiple sites in NEDD8 itself, ubiquitin and SUMO for the viable formation of 
polyNEDD8 and mixed chains with different linkages. NEDD8 could be forming a 
proximal or distal modification within the chains. In fact, previous studies have 
 108 
proposed that NEDD8 could act as a chain terminator for polyubiquitin chains due 
to the Lys60 conserved in NEDD8 but not ubiquitin which prevents the further 
ubiquitination of NEDD8 (Choi, Jeon, Ryu, & Cheong, 2009; Singh et al., 2012). 
The formation of mixed NEDD8-ubiquitin, NEDD8-SUMO, SUMO-ubiquitin 
chains together with the possibility to form them via distinct linkages, generate a 
more complex view of the ubiquitin code. Additionally, these chains are not 
excluded to crosstalk with other UBLs and also with other PTMs such as 
phosphorylation, acetylation, and methylation. Indeed, recent analyses have 
confirmed the high crosstalk between ubiquitination and SUMOylation with 
acetylation and phosphorylation (I A Hendriks et al., 2014; Ivo A Hendriks et al., 
2017; Herhaus & Dikic, 2015). Thus, determining the mechanisms, functions and 
dynamic of the more complicated ubiquitin code is an important direction for 
future research. 
 
We could reconfirm and distinguish the modification sites for all the NEDD8 
conjugating enzymes yielding autoNEDDylation due to NEDP1 depletion. For 
example, we identified the modification of the E1 regulatory subunit NAE1 
(APPBP1) at K6 and K341 and the E1 catalytic subunit UBA3 (UBE1C) at K398, 
K409, K434 and K458. Strikingly, these sites are already annotated in the 
PhosphositePlus database of diglycine identification for ubiquitination as many 
other sites, except for K458 in UBA3. This observation suggests that the 
modification sites might be related to NEDD8 conjugation and not ubiquitin as the 
tryptic GG remnant can not discriminate between both. Another possibility is that 
certainly all these sites can be modified by NEDD8 and ubiquitin, and that 
potentially NEDD8 can exclusively modify UBA3 at the C-terminal site K458. We 
could also identify the modification sites for the NEDD8 E2 conjugating enzymes 
UBE2M (Ubc12) at K3, K8, K36, K45 and UBE2F at K7 and K9. The UBE2M 
autoNEDDylation was recently identified and characterized both in vitro and in 
vivo. The analyses confirm the catalytic Cys residue-dependant NEDD8 covalent 
conjugation of UBE2M at its extreme N-terminus (K3) which is different from its 
Cys active site that forms the UBE2M∼NEDD8 thioester intermediate (Coleman 
et al., 2017; Huang et al., 2007). As observed in previous structural studies, the 
N-terminus of UBE2M is the region required for the interaction with the 
hydrophobic binding pocket of DCN1 (Scott, Monda, Bennett, Harper, & 
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Schulman, 2011). This finding might explain the reason why the NEDDylation of 
UBE2M impede the DNC1-UBE2M complex conformation (Coleman et al., 2017). 
Similar results have been shown by the SUMOylation of the ubiquitin-conjugating 
enzyme E2 K (UBE2K) at Lys14 N-termini, which blocks the interactions and 
further conjugation activity with the ubiquitin E1 and E3 enzymes (Pichler et al., 
2005). In fact, we could also see that NEDD8 modifies not only its conjugation 
machinery but also some enzymes of the ubiquitin machinery as well as 
ubiquitination regulators such as UBE1 (the E1 for atypical NEDDylation), 
UBE2Z, USP3, RNF8, CAND1, and VCP. As mentioned above, it is possible that 
the NEDDylation of proteins directly alters conformations and/or impede protein 
interactions as observed in these examples. In conclusion, our findings suggest 
that the crosstalk of NEDD8, ubiquitin and probably SUMO is not only limited to 
the regulation and competition of downstream substrates but also for the 
upstream enzymatic pathways. 
 
Here we provide for the first time a large-scale specific modification site database 
for NEDDylation. It is well established that the NEDDylation on cullins occur in 
the consensus motif IVRIMKMR whitin C-terminal’s winged helix-binding (WHB) 
(Duda et al., 2008; Pan et al., 2004). Therefore, we used our NEDDylation site 
database to investigate the existence of a sequence motif for NEDDylation 
besides the cullins consensus motif. This sequence analysis provided us a global 
scale picture of the fundamental amino acid nature of lysines utilized for NEDD8 
modifications, but we could not estimate a precise motif for NEDDylation. 
Previous studies have predicted a sequence motif for ubiquitination (Kim et al., 
2011), but as for NEDDylation its occurrence is not readily apparent as in the 
case for the basal SUMOylation consensus motif ΨKXE-type which has been 
widely described as a required subject for the direct binding with the SUMO-
conjugating enzyme UBC9 (Bernier-Villamor, Sampson, Matunis, & Lima, 2002). 
A particular consistency between our NEDDylation motif analysis with the 
SUMOylation and GG base ubiquitination analysis is the striking reduce of 
cysteines around the modified lysines wich greatly confirm the physiological 
avoidance of cysteine thioester linkage formation. At least two possible reasons 
are compatible with the lower evidence of ubiquitination and NEDDylation 
consensus motif. First, it could be that both modifications occur promiscuously at 
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various lysine residues. Secondly, it might be that different modification motifs 
exist for certain groups of proteins as it has been observed for SUMOylation ((Ivo 
A. Hendriks & Vertegaal, 2016). Here, our NEDDylation sequence analysis 
revealed a similar ubiquitination preference for negative charge aminoacids 
surrounded the modified lysine residue, most notably for glycines and glutamic 
acids. Likewise, a slight reduced in positive charge residues such as histidine and 
arginine was observed. The most striking difference in the analysis is that in our 
NEDDylation motif we found a great increase in lysine residues which in the 
ubiquitination analyses was strongly diminished. Given that the polar and 
charged surfaces between ubiquitin and NEDD8 are the less conserved 
properties (Whitby et al., 1998), the motif differences will influence to discriminate 
in their potential specific modification sites, interactions and final functions. 
Unfortunately, because of the inability of the GG remnant approach to 
discriminate between NEDD8 and ubiquitin conjugation, it has not been 
determined a large-scale database for genuine ubiquitination sites. Clearly, 
separate specific databases for NEDDylation and ubiquitination sites will be 
necessary for future research on consensus motif. The sequences motif analysis 
definitely represents a key element to study the structural elements in lysine 
recognition for post-translational modifications and therefore gain a better 
prediction for NEDD8, ubiquitin and SUMO sites and targets.  
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PERSPECTIVES 
 
In this work, we used the advantages of the depletion of NEDP1 protease 
together with the endogenous levels expression of a transgene NEDD8 R74K as 
a strategy which provided the broadest identification of specific NEDDylation 
substrates and sites. Nevertheless, certain limitations of our strategy can be 
improved. Unquestionably, further research in NEDDylation proteomics should 
be conducted to develop approaches to analyse endogenously expressed 
NEDD8 modifications. In fact, we are still lacking methods that allow to identify 
site-specific level of endogenous ubiquitin and SUMO which would provide a 
better reliable comparison of these UBLs modifications. An alternative for this 
could be to perform an endogenous NEDD8 R74K mutant by using the genome 
editing CRISPR/Cas9 approach. However, given that the NEDD8 mutation 
potentially can alter its activation and further conjugation (especially as observed 
during atypical NEDDylation), it will be important to avoid the use of NEDD8 
mutants. One possibility to prevent the use of NEDD8 mutant but still ensure 
NEDD8 specificity is by adapting the protease-reliant identification technique 
which has beed succesfully use for the identification of SUMO modification sites, 
called PRISM (protease-reliant identification of SUMO modification) (Ivo A 
Hendriks et al., 2015). The disadvantage of this strategy is that even it can identify 
modification sites whithout a modifier mutation, still needs the transgene 
expression. Definitely, further studies should be conducted to the development of 
a highly selective antibodies recognizing the different NEDDylation and 
ubiquitination Lys-C remnant to perform a global analysis of a genuine 
endogenous human NEDDylome and ubiquitinome. In conclusion, here we 
provided a first large-scale dataset of potentially specific NEDDylated sites and 
substrates. We are confident that our resource will be useful knowledge for the 
NEDD8 and general ubiquitin-like proteins field. 
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